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Abstract
The skin cancer incidence has increased substantially over the past decades 
and the role of ultraviolet (UV) radiation in the etiology of skin cancer is well 
established. Ultraviolet B radiation (280–320 nm) is commonly considered as 
the more harmful part of the UV-spectrum due to its DNA-damaging potential 
and well-known carcinogenic effects. Ultraviolet A radiation (320–400 nm) is 
still regarded as a relatively low health hazard. However, UVA radiation is 
the predominant component in sunlight, constituting more than 90% of the 
environmentally relevant solar ultraviolet radiation. In the light of the recent 
scientiﬁc evidence, UVA has been shown to have genotoxic and immunologic 
effects, and it has been proposed that UVA plays a signiﬁcant role in the 
development of skin cancer. Due to the popularity of skin tanning lamps, which 
emit high intensity UVA radiation and because of the prolonged sun tanning 
periods with the help of effective UVB blockers, the potential deleterious effects 
of UVA has emerged as a source of concern for public health. 
The possibility that UV radiation may affect melanoma metastasis has not 
been addressed before. UVA radiation can modulate various cellular processes, 
some of which might affect the metastatic potential of melanoma cells. The aim 
of the present study was to investigate the possible role of UVA irradiation on 
the metastatic capacity of mouse melanoma both in vitro and in vivo. The in vitro 
part of the study dealt with the enhancement of the intercellular interactions 
occurring either between tumor cells or between tumor cells and endothelial 
cells after UVA irradiation. The use of the mouse melanoma/endothelium in vitro 
model showed that a single-dose of UVA to melanoma cells causes an increase in 
melanoma cell adhesiveness to non-irradiated endothelium after 24-h irradiation. 
Multiple-dose irradiation of melanoma cells already increased adhesion at a 1-h 
time-point, which suggests the possible cumulative effect of multiple doses of 
UVA irradiation. This enhancement of adhesiveness might lead to an increase in 
binding tumor cells to the endothelial lining of vasculature in various internal 
organs if occurring also in vivo. A further novel observation is that UVA induced 
both decline in the expression of E-cadherin adhesion molecule and increase in 
the expression of the N-cadherin adhesion molecule. In addition, a signiﬁcant 
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decline in homotypic melanoma-melanoma adhesion (clustering) was observed, 
which might result in the reduction of E-cadherin expression. It appears that UVA 
irradiation might reduce melanoma-melanoma interaction through decreasing 
the expression of E-cadherin and simultaneously enhance the adhesiveness of 
melanoma cells to endothelium, which in part could be mediated by N-cadherin 
expression. 
The aim of the in vivo animal study was to conﬁrm the physiological 
signiﬁcance of previously obtained in vitro results and to determine whether 
UVA radiation might increase melanoma metastasis in vivo. The use of C57BL/6 
mice and syngeneic melanoma cell lines B16-F1 and B16-F10 showed that mice, 
which were i.v. injected with B16-F1 melanoma cells and thereafter exposed to 
UVA developed signiﬁcantly more lung metastases when compared with the non-
UVA-exposed group. To study the mechanism behind this phenomenon, the direct 
effect of UVA-induced lung colonization capacity was examined by the in vitro 
exposure of B16-F1 cells. Alternatively, the UVA-induced immunosuppression, 
which might be involved in increased melanoma metastasis, was measured by 
standard contact hypersensitivity assay (CHS). It appears that the UVA-induced 
increase of metastasis in vivo might be caused by a combination of UVA-induced 
systemic immunosuppression, and to the lesser extent, it might be caused by the 
increased adhesiveness of UVA irradiated melanoma cells. 
Finally, the UVA effect on gene expression in mouse melanoma was 
determined by a cDNA array, which revealed UVA-induced changes in the 9 
differentially expressed genes that are involved in angiogenesis, cell cycle, stress-
response, and cell motility. These results suggest that observed genes might be 
involved in cellular response to UVA and a physiologically relevant UVA dose 
have previously unknown cellular implications.
The novel results presented in this thesis offer evidence that UVA exposure 
might increase the metastatic potential of the melanoma cells present in blood 
circulation. Considering the well-known UVA-induced deleterious effects on 
cellular level, this study further supports the notion that UVA radiation might 
have more potential impact on health than previously suggested. The possibility of 
the pro-metastatic effects of UVA exposure might not be of very high signiﬁcance 
for daily exposures. However, UVA effects might gain physiological signiﬁcance 
following extensive sunbathing or solaria tanning periods. Whether similar 
UVA-induced pro-metastatic effects occur in people sunbathing or using solaria 
remains to be determined. In the light of the results presented in this thesis, the 
avoidance of solaria use could be well justiﬁed.
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PASTILA Riikka. STUK-A216. Pitkäaaltoisen UV-säteilyn vaikutus hiiren 
melanoomaan in vitro ja in vivo. Helsinki 2006. 125 s + liitteet 55 s (vain sidotussa 
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Avainsanat  Ultravioletti A-säteily, melanooma, solujen välinen adheesio, 
metastasia, immunosuppressio, geenien ilmentyminen
Tiivistelmä
Ihosyöpien ilmaantuvuus on lisääntynyt voimakkaasti viimeisten vuosikym-
menten aikana ja ultraviolettisäteilyn (UV-säteilyn) vaikutus ihosyöpien ilmaan-
tuvuuteen on kiistaton. Ultravioletti B-säteily (280–320 nm) on tunnetusti haital-
lista DNA:ta vaurioittavien ja karsinogeenisten vaikutustensa vuoksi. Ultravio-
letti A-säteilyn (320–400 nm) terveysvaikutuksia on puolestaan pidetty pitkään 
harmittomampana kuin UVB-säteilyn vaikutuksia. Maanpinnalle saapuvasta 
auringonvalosta kuitenkin yli 90 % on UVA-säteilyä. Viimeaikaisten tutkimustu-
losten perusteella UVA-säteilyllä on kuitenkin havaittu olevan perimää vaurioit-
tavia ja immunologisia vaikutuksia ja lisäksi sillä saattaa olla myös merkittävä 
rooli ihosyöpien kehittymisessä. UVA-säteilyaltistuksen aiheuttamat epäsuo-
tuisat terveysvaikutukset ovat nousseet huolenaiheeksi ihmisten ruskettaessa 
itseään solariumeissa, jotka säteilevät voimakasta UVA-säteilyä, tai ottaessa 
pitkiä aikoja aurinkoa tehokkaiden UVB-aurinkosuojien turvin, jotka suojelevat 
ihoa tehokkaasti UVB-säteilyn aiheuttamalta palamiselta suojaten vähemmän 
UVA- kuin UVB-säteilyltä.
UV-säteilyn vaikutuksia melanooman kykyyn lähettää etäpesäkkeitä ei ole 
tutkittu aikaisemmin. UVA-säteilyn on kuitenkin havaittu aiheuttavan soluissa 
monia sellaisia fysiologisia muutoksia, jotka saattavat vaikuttaa solujen kykyyn 
lähettää etäpesäkkeitä (metastasoida). Tämän väitöstutkimuksen tarkoituksena 
oli tarkastella UVA-säteilyn vaikutusta hiiren melanoomasolujen metastaatti-
siin ominaisuuksiin in vitro ja in vivo. In vitro -osiossa tutkittiin UVA-säteilyn 
vaikutusta melanoomasolujen ja endoteelisolujen väliseen sitoutumiseen sekä 
melanoomasolujen keskinäiseen sitoutumiseen. Yksittäisen UVA-säteilyannoksen 
havaittiin lisäävän melanoomasolujen adhesiivisuutta säteilyttämättömiin endo-
teelisoluihin 24 tuntia UVA-säteilytyksen jälkeen. Kun melanoomasolut altis-
tettiin jakamalla säteilyannos useisiin pienempiin osiin, UVA-säteilyn adhesii-
visuutta lisäävä vaikutus havaittiin jo 1 tunnin kuluttua. Tämä viittaa UVA-
säteilyn mahdollisiin kumulatiivisiin vaikutuksiin sekä siihen, että UVA-säteily 
saattaa lisätä melanoomasolun adhesiivisuutta in vivo ja tällöin sen kiinnit-
tyminen verisuonen endoteeliin kohde-elimessä saattaa lisääntyä. Uusi löytö 
oli myös UVA-säteilyn vaikutus kadheriini-adhessiomolekyylien ilmenemiseen 
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melanoomasolun pinnalla siten, että E-kadheriinin ilmeneminen laski mutta 
N-kadheriinin ilmeneminen nousi UVA-säteilyn vaikutuksesta. Samanaikaisesti 
havaittiin melanoomasolujen keskinäisessä sitoutumisessa vähenemistä UVA-
säteilyn vaikutuksesta. UVA-säteily saattaa siis vähentää melanoomasolujen 
keskinäistä sitoutumista E-kadheriinin vähenemisen kautta, ja samalla lisätä 
melanoomasolun adheesiota endoteeliin lisäämällä N-kadheriinin ilmenemistä 
melanoomasolujen pinnalla.
Saatuja tuloksia tarkasteltiin myös in vivo -hiirimallissa, jossa tutkittiin, 
ovatko in vitro-havainnot melanoomasolujen adhesiivisuudessa fysiologisesti 
merkittäviä ja sitä, lisääkö UVA-säteily melanooman etäpesäkkeiden muodostu-
mista C57BL/6-hiirissä. C57BL/6-hiiriin injektoitiin i.v. häntälaskimosta mela-
noomasoluja, jonka jälkeen hiiret altistettiin in vivo välittömästi UVA-säteilylle. 
UVA-annoksen havaittiin lisäävän keuhkometastaasien määrää UVA-käsitel-
lyissä hiirissä verrattuna kontrolliryhmään, jotka eivät olleet saaneet säteilyä. 
Melanoomasoluja UVA-altistettiin myös in vitro ennen hiireen injektoimista 
tutkittaessa UVA-säteilyn suoraa vaikutusta melanoomasolujen metastaatti-
seen kapasiteettiin. Vaihtoehtoisesti mitattiin UVA-säteilyn aiheuttama immu-
nosuppressio, joka saattaa myös vaikuttaa melanooman etäpesäkkeiden muodos-
tamiskykyyn käyttämällä paikallista yliherkkyysreaktio-menetelmää (contact 
hypersensitivity, CHS-menetelmä). Tutkimusten mukaan UVA-säteilyn kyky 
lisätä hiiren melanoomasolujen metastaattista aktiivisuutta saattaa johtua sekä 
UVA-säteilyn suorista vaikutuksista melanoomasoluihin ja myös sen aiheutta-
masta immunosuppressiosta.
Tutkimuksen viimeisessä osiossa tarkasteltiin UVA-säteilyn vaikutusta 
hiiren melanoomasolujen geeniekspressioon eli geenien ilmentymiseen cDNA-
menetelmällä. UVA-säteilyn havaittiin muuttavan yhdeksän geenin ilmenemis-
proﬁilia melanoomasoluissa säteilytyksen jälkeen. Havaittujen geenien tiedetään 
osallistuvan soluissa verisuonten uudismuodostukseen, solusykliin, stressivas-
teeseen ja solun liikkuvuuteen. Näiden tulosten perusteella havaittujen geenien 
voidaan arvella olevan osa UVA-säteilyn aiheuttamaa soluvastetta ja sen lisäksi 
osa UVA-säteilyn aiemmin tuntemattomia vaikutuksia soluissa.
Tässä väitöstutkimuksessa on osoitettu ensimmäistä kertaa, että UVA-
säteily saattaa lisätä verenkierrossa olevien melanoomasolujen metastaat-
tista kapasiteettia. Nämä tulokset tukevat aiempien tutkimustulosten näke-
mystä siitä, että UVA-säteilyllä saattaa olla enemmän terveysvaikutuksia kuin 
aiemmin on osattu epäillä. Jokapäiväisessä elämässä UVA-säteilyn vaikutukset 
ovat pieniä, mutta ne saattavat olla merkityksellisiä solariumia käytettäessä tai 
otettaessa pitkään aurinkoa, jolloin altistuminen UVA-säteilylle on voimakasta. 
UVA-säteilyn vaikutukset ihmisen melanooman kykyyn lähettää etäpesäkkeitä 
jää vielä selvitettäväksi. Näiden tutkimustulosten perusteella solariumin käytön 
välttäminen voi kuitenkin olla aiheellista.
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Introduction
Ultraviolet radiation is the major environmental risk factor for non-melanoma 
and melanoma skin cancer formation due to its DNA-damaging potential and 
mutagenic and mitogenic actions. In addition, ultraviolet radiation-derived 
immunosuppression has been identiﬁed as a risk factor for skin cancer induction. 
The terrestrial spectrum of solar UV radiation consists, depending on latitude 
and season of the year, of 1–5% ultraviolet B radiation (280–320 nm), whereas the 
majority of the radiation reaching the Earth’s surface belongs in the ultraviolet 
A (320–400 nm) region. Moreover, when reaching the skin, UVB is almost 
completely absorbed by the stratum corneum and top layers of the epidermis, 
whereas up to 50% of incident UVA radiation penetrates Caucasian skin deep 
into the dermis, and irradiates the full thickness of the skin. The carcinogenic 
potential of UVB is well known and understood but the role of ultraviolet-A 
radiation in photocarcinogenesis is obscure. The role of UVA as a risk factor 
has been elucidated over the past 10–15 years. It is known that UVA exerts its 
biological effect mainly by producing reactive oxygen species (ROS) that promote 
biological damage in exposed tissue. UVA radiation has been shown to participate 
in the pathogenesis of non-melanoma skin cancer in mouse models and in human 
skin carcinoma samples. The role of UVA in the development of melanoma has 
been elucidated mainly through animal studies, and some of these have indicated 
a positive association between the onset of melanoma and UVA exposure. 
The most threatening characteristic of malignant melanoma is its 
extremely high potential to develop metastasis. Although most individuals with 
primary cutaneous melanoma can be cured surgically, the prognosis of patients 
with metastatic disease remains poor. Thus, there is a need to gain a better 
understanding of the mechanisms involved in the progression of melanoma to 
metastatic disease. 
UVA radiation can modulate various cellular processes, some of which 
might affect tumor development. Some UVA-induced cellular effects, such as the 
upregulated expression of matrix degrading enzymes and certain interleukins 
and adhesion molecules, may enhance the metastatic potential of cancer cells. 
Thus, UVA is capable of inducing such biochemical responses in the skin and 
the microvasculature that could enhance tumor metastasis. However, the effect 
of UVA on melanoma metastasis has been not studied widely thus far. The 
possibility of the pro-metastatic effects of UVA/solar UV might not be of relevance 
for daily low exposure, but they may gain signiﬁcance during sunbathing or 
tanning on sun-beds, when people are exposed to large doses of predominantly 
UVA radiation. So far, this possibility has not been investigated. If proven, it 
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would suggest that exposure to UVA radiation during sun and solarium tanning 
might have negative health effects. 
This thesis places special emphasis on investigating the hypothesis that 
UVA radiation may enhance the metastatic potential of melanoma cells in the 
C57BL/6 mouse model. The overall objective of the work is to characterize the role 
of UVA as a possible metastatic enhancer in the in vitro and in vivo approaches. 
In order to achieve these aims, the focus in this work was 
• to examine the UVA induced alterations in melanoma adhesiveness in 
vitro 
• to determine the physiological signiﬁcance of UVA exposure on melanoma 
metastasis in vivo 
• to study the possible effect of UVA on melanoma gene expression 
14
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1. Review of the literature
1.1 Ultraviolet radiation
1.1.1 Deﬁnition and sources of ultraviolet radiation
UVR is located in the electromagnetic spectrum between the ionizing x-rays 
and the non-ionizing visible light (Figure 1). It spans a wavelength of 100–400 
nanometers (nm), being non-ionizing and non-visible. Since the biological effects 
of UVR vary greatly with wavelength, it has further been divided into the three 
subclasses: shortwave ultraviolet-C (UVC), mid-wave ultraviolet-B (UVB) and 
long-wave ultraviolet-A (UVA) radiation. The wavelength deﬁnitions of the 
subclasses are arbitrary and differ depending on the ﬁeld of interest (Diffey 
2002). In the area of photobiology and photomedicine, the spectral distribution 
is often deﬁned as follows: UVC ranges from 100/200 nm to 280/290 nm, UVB 
ranges from 280/290 nm to 315/320 nm and UVA ranges from 315/320 to 400 nm. 
Since the shorter wavelengths are photobiologically more active, wavelengths 
from 320 to 340 are deﬁned as the UVAII region and 340–400 nm as the UVAI 
region (Urbach 1992). 
The intensity of terrestrial UVR is attenuated largely in the atmosphere, 
where ozone, clouds, and pollutants scatter and absorb ultraviolet rays and thus 
modify the quality (spectrum) and quantity (intensity) of solar UVR (Diffey 
2002). The spectrum and intensity of UVR vary largely with latitude and solar 
altitude, which depends on time of day, season and geographical location. The 
atmospheric ozone in the stratosphere absorbs all UVC and most UVB radiation. 
However, the ozone layer does not signiﬁcantly attenuate UVA wavelengths and 
it has very little inﬂuence on the ambient UVA level: absorption by the ozone 
layer decreases to essentially zero in the region from 350–400 nm (Frederick & 
Alberts 1992). Thus, the terrestrial spectrum of ultraviolet radiation consists, 
depending on latitude and season of the year, of 1-5% UVB radiation and 95–99% 
of UVA radiation. 
Sunlight is the most prominent source of ultraviolet radiation (UVR) for 
humans. However, several artiﬁcial UV sources (UV lamps) have been developed 
for use in tanning devices, for germicidal purposes and for the therapeutic use 
of UV radiation (phototherapy). Depending on the lamp type and ﬁlters used, 
UV sources can provide very different UV spectra from the broadband solar-
simulated radiation spectrum to speciﬁc narrow-band applications. 
15
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1.1.2 Human exposure to UVA radiation
Human exposure to UVR, including UVA radiation, is on the rise not only because 
of the environmental factors, but also due to human activity and behavior. The 
human population is increasingly exposing itself to UVR due to changes in 
lifestyle, such as a decrease in body clothing and an increase in leisure time 
(Kricker et al. 1993). Diffey has estimated that one of the major contributors 
for the annual accumulation of UVA exposure is seasonal variation in behavior 
(Diffey 1998a). Autier et al. have shown that recreational exposure, sunbathing 
and the number of holiday weeks spent annually in sunny resorts was a signiﬁcant 
risk factor for the development of melanoma (Autier et al. 1994b). The  annual 
cumulative UVA dose from the sun has been estimated to be 7700 kJ/m2, and for 
more avid tanners, it is as much as 19 250 kJ/m2 (Wang et al. 2001). Recently, 
a lot of attention has been drawn to the fact that sunscreens, while efﬁciently 
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Figure 1. Ultraviolet radiation is located in the electromagnetic spectrum between the 
ionizing x-rays and the non-ionizing visible light, spanning in the wavelength region of 
100–400 nanometers. Ultraviolet radiation has been divided into the three subclasses: 
shortwave ultraviolet-C (UVC), mid-wave ultraviolet-B (UVB) and long-wave ultraviolet-
A (UVA) radiation.
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absorbing in the UVB range, are generally poor UVA absorbers (Wang et al. 
2001). Through using effective UVB blocks during tanning, sunbathers protect 
themselves from developing painful erythema, which is mainly caused by UVB. 
However, this may lead to longer tanning periods and as a consequence, larger 
UVA doses up to as much as 100 J/cm2 per day (Kimlin et al. 2002). Extensive 
tanning in solaria leads to increased UVA exposure. In the 1980s, growing 
scientiﬁc evidence for the genotoxic, immunotoxic and carcinogenic effects of 
UVB radiation encouraged solaria manufacturers to change the physical spectral 
properties of UV device towards the UVA region. As a result, solaria devices that 
may emit up to 5–10 times more UVA when compared to natural solar radiation 
came onto the market. 
UVA and UVB radiation have different biological effects on skin. UVB 
radiation is more potent and effective in causing biological damage; photon energy 
grows along with the shorter wavelength. UVB wavelengths are estimated to 
contribute 80% of the harmful effects of exposure to the sun and UVA is estimated 
to contribute the remaining 20% (Diffey 1998b). The depth of penetration into 
human skin is also different for UVA and UVB (Figure 2). Predominantly, UVB 
radiation directly affects the epidermis, and only 10–20% of it penetrates to the 
dermis. However, UVA penetrates deeper when compared to UVB because of its 
longer wavelength, and ~50% of incident UVA penetrates into the papillary and 
reticular dermis (Parrish 1983;Bruls et al. 1984). This difference in penetration 
depth is likely to affect the biological effects induced by UVA and UVB. UVR has 
been shown to induce DNA damage in circulating blood cells in skin capillaries 
(Moller et al. 2002) and to cause the necrosis and loss of dermal endothelial 
cells in capillary venules, thus damaging dermal blood vessels (Margolis et al. 
1989;Clydesdale et al. 2001). Finally, the stem cells in the basal layer of skin 
divide and are less differentiated and thus, they are more prone to the malignant 
changes induced by the deep penetration of UVA (Matsui & DeLeo 1991). 
1.1.3 The visible effects of UV on human skin 
Human skin types have been divided into the six categories based on the 
facultative skin color that  reﬂects genetically determined sensitivity to sunburn 
and the ability to tan (Fitzpatrick 1988). UVR has both acute and chronic effects 
on human skin. The acute signs of UV exposure are pigmentation (tanning), 
erythema (sunburn) and the synthesis of vitamin D, which is one of the rare 
beneﬁcial health effects of UVB radiation on the skin. Vitamin D is required for 
the proper absorption of calcium from the intestines, thus regulating calcium 
homeostasis and maintaining skeletal health. Chronic exposure to UVR causes 
premature skin aging and increases the risk of skin cancer. Pigmentation and 
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the production of vitamin D, though for different reasons, are viewed as desirable 
consequences of UV radiation. However, erythema and photoaging are widely 
recognized as the adverse effects of exposure, mainly because of their close 
association with malignant skin transformations such as actinic/solar keratosis 
(AK/SK) and, ultimately, skin cancer.
1.1.3.1 UV-induced pigmentation and hyperkeratosis
Melanin is the major pigment in the skin and it is a natural human photoprotector. 
Melanin is produced and stored by the neural-crest-derived melanocytes that 
are aligned along the basement membrane. Each melanocyte reaches with it 
dendrites into the upper layer of the epidermis and transports melanosome 
granules ﬁlled with melanin to approximately 36 keratinocytes (Jimbow 1995; 
Seiberg 2001). Melanin accumulates inside the cells as a nuclear cap and protects 
cells from the damaging effects of UVR by absorbing and scattering UV rays and 
by scavenging the UV-induced oxygen radicals. Two kinds of melanin exist in 
the epidermis: brown eumelanin and red pheomelanin. Eumelanin is believed 
���� ����� �� ���� ���
������������ ��� ���������
���� ����� �� ���� ���
������������ ��� ������
�������
�������� ����� ��
�����
����� �����
����� ����������
������
������
�� �� �� �
���������
��� �� ���� ��
Figure 2. The penetration depth of UVB and UVA in skin. UVB radiation affects mainly 
in epidermis. UVA penetrates deeper as compared to UVB, because of its longer 
wavelength, and ~50% of incident UVA penetrates into the papillary and reticular 
dermis.
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to be photoprotective, acting as a free radical scavenger, whereas pheomelanin 
can act as a photosensitizer, being potentially phototoxic due to the generation 
reactive oxyfgen species that might contribute to oxidative DNA damage (Krol 
& Liebler 1998; De Leeuw et al. 2001; Kadekaro et al. 2003). 
Skin pigmentation response is biphasic following UV exposure. It comprises 
immediate tanning induced mainly by UVA radiation and the delayed formation 
of new pigment induced primarily by UVB radiation (Parrish et al. 1982). 
Immediate pigment darkening (IPD) is a transient change in skin color due to 
the oxidation of pre-existing melanin and melanin precursors (Honigsmann et 
al. 1986; Gilchrest et al. 1996). IPD is induced by the whole UVA spectrum up to 
visible light at 470 nm (Rosen et al. 1990; Irwin et al. 1993), with a threshold dose 
of 1-2 J/cm2 (Honigsmann 2002). Interestingly, IPD has neither been found to be 
protective against UVB-induced erythema (Black et al. 1985) nor UVB induced 
DNA lesions (Honigsmann et al. 1986;Cesarini 1992). However, it may provide 
additional protection against further UVA-induced cutaneous injury, mainly the 
inﬁltration of mononuclear cells into skin (Margolis et al. 1989). With higher UVA 
doses (>20 J/cm2) the change in skin color may persist for several days (Kollias 
et al. 1991). This type of pigmentation is called persistent pigment darkening 
(PPD). PPD is used to determine the UVA protection factor in sunscreens (Moyal 
et al. 2000a; Moyal et al. 2000b). 
UVR-induced delayed tanning (DT) – melanin synthesis (melanogenesis) – 
is stimulated mainly by UVB radiation and to a lesser extend by UVA exposure 
(Agar & Young 2005). The production of new melanin is a photochemically 
initiated, tyrosinase-controlled production of melanin polymers from pre-existing 
monomers inside the melanocytes (Bech-Thomsen 1997;Honigsmann 2002). 
Other skin cells assist the melanogenesis by secreting paracrine factors such 
as the a-melanocytic stimulating hormone (a-MSH) and endothelin-1 (ET-1). 
These, in turn, stimulate melanin synthesis and melanocyte migration, enhance 
their dendricity and survival rate during subsequent UV exposure (Jimbow 
1995; Agar & Young 2005). The newly synthesized pigment appears 3–5 days 
after exposure, peaking after one week (Kollias et al. 1991). UVAI produces an 
increased melanin density mostly on the basal cell layer, whereas the UVAII 
region and UVB increase the synthesis and transfer of melanosomes to the upper 
epidermis (Honigsmann 2002). 
There is growing evidence that activation of the tyrosinase enzyme may 
be initiated by UV-induced DNA damage (Eller et al. 1996;Gilchrest et al. 
1996), which suggests that erythema and melanogenesis may have the same 
chromophore, DNA (Young et al. 1998a). This is further supported by the notion 
that the action spectrum for delayed pigmentation and for erythema formation 
have been found to be similar in fair skin types I and II (Parrish et al. 1982; Gange 
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1986). The ability to tan has been considered photoprotective, since darker skin 
types are at a lower risk of sunburn formation and apparently of DNA damage. 
However, melanin is not an effective sunscreen in Caucasian skin, offering a 
sun protection factor of 1.5–3. Moreover, it has been shown that photoprotection 
against erythema and DNA damage is independent of induced tan in fair skin 
types, offering quite poor photoprotection (Sheehan et al. 1998). It has also been 
observed that skin type IV has faster DNA repair capacity after UV exposure 
than skin type II does (Sheehan et al. 2002). These results postulate the notion 
that skin pigmentation ability, i.e. skin type, is a measure of inducible DNA 
repair capacity (Agar & Young 2005) more than a marker of protection through 
the formation of pigment. 
Skin hyperplasia occurs as a result of an increased proliferation of 
keratinocytes in the lower epidermis and from the increased thickness of the 
stratum corneum. The skin thickening increases the optical path length and 
thus leads to an increased protection of the underlying tissues against UV 
exposure by a sun protection factor of 5 or higher (Diffey 1998b), regardless of 
melanogenesis (Parrish 1983). This adaptive process does not involve genetic 
predisposition and it might be the major protective factor for poorly tanning 
individuals (Diffey 2004). 
1.1.3.2 Erythema (sunburn) 
Erythema, an acute skin injury following excessive UV exposure, is the most 
obvious and prevalent effect of UVR on human skin. Individual sensitivity, which 
varies greatly from one subject to another, is assessed by the minimal erythema 
dose (MED), which is deﬁned as the minimal dose required in order to elicit an 
observable reddening (erythema) on previously unexposed skin. However, MED is 
subjective and does not represent a deﬁned physical measure of irradiation. For 
this reason the standard erythema dose (SED) was proposed  as an equivalent 
to an erythemal effective radiation of 100 J/m2 (Diffey et al. 1997).
According to a reference erythema action spectrum by Commission 
Internationale de l’Eclairage (CIE) (McKinlay & Diffey 1987), erythemal 
effectiveness declines rapidly with the increasing UV wavelength. UVB radiation 
is approximately 1000 times more efﬁcient in causing sunburn when compared 
to UVA radiation (Matsui & DeLeo 1991). UVA has been estimated to contribute 
approximately 14% of the erythemal UVR in sunlight (Parisi & Wong 2000). 
Following UVB exposure, there is a latent period of 2–4 hours before the UVB-
induced erythema develops. The maximum intensity of erythema is reached 
within 8–24 hours after UVB exposure (Honigsmann 2002). The time course 
for UVA-induced erythema is biphasic, consisting of immediate and delayed 
erythema formation. Immediate erythema already develops during irradiation 
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and thereafter decreases within 4 hours. Delayed erythema develops 6–24 hours 
after UVA exposure (Gilchrest et al. 1983; Diffey et al. 1987; Ortel & Gange 
1992).
The chromophores that initiate sunburn inﬂammation have not been 
precisely identiﬁed, but a comparison of erythema action spectra and epidermal 
DNA photodamage showed that DNA is the major chromophore for erythema 
formation (Young et al. 1998a). There are also some other chromophores in 
the UVAII region, the nature of which is yet unidentiﬁed, mediating the DNA 
damage via oxygen species (Anders et al. 1995). This suggests that a principal 
event in erythema formation would be the direct damage of DNA by UVB and 
UVAII wavelengths (Parrish et al. 1982). DNA photodamage has been shown to 
be the major determinant of sunburn cell (SBC) formation in the epidermis. It is 
one of the characteristic events in the epidermis following acute UVB exposure 
or after UVA irradiation in the presence of psoralens, at doses of around or 
above 1 MED (Murphy et al. 2001). SBCs have been identiﬁed as keratinocytes 
undergoing apoptosis in a process controlled by both p53-dependent and p53-
independent manners (Murphy et al. 2001; Sheehan & Young 2002). SBCs can 
be distinguished on the basis of their distinctive appearance, i.e. pyknotic nuclei 
and a shrunken and eosinophilic cytoplasm. SBC formation is believed to be a 
protective mechanism that eliminates damaged cells that are at risk of developing 
malignant transformations. 
The initial UV-induced inﬂammatory response is the vasodilatation of skin 
capillaries that leads to augmented blood ﬂow and increased leukocyte inﬁltrates in 
the skin (Terui & Tagami 2000; Clydesdale et al. 2001; Rhodes et al. 2001). In UVB-
induced erythema, vasoactive prostaglandins (PGs) and nitric oxide (NO) mediate 
erythema formation by diffusing from the epidermis to the dermal skin capillaries 
(Clydesdale et al. 2001). It is supposed that UVA induces erythemal response by 
affecting either directly the skin capillaries or via diffusible mediators (Kelfkens 
et al. 1990). Many cytokines, such as interleukins (IL) IL-1, IL-6, IL-8, IL-10, IL-
12, tumor necrosis factor-a (TNF-a), and interferon-g (IFN-g), are synthesized 
and released within the skin by keratinocytes and leukocyte inﬁltrates (Terui 
& Tagami 2000; Honigsmann 2002). They regulate the expression of adhesion 
molecules in keratinocytes and in vascular endothelium and thus, they are 
involved in recruiting of the polymorphonuclear leukocytes that play a pivotal 
role in the UV(B)-induced erythema.
1.1.3.3 Skin photoaging
Photodamage of the skin is the result of chronic exposure to UV radiation. 
Photoaging predisposes to the formation for solar keratosis, which is considered a 
precursor of squamous cell carcinoma (SCC). The clinical symptoms of photoaged 
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skin are dryness, roughness, deep wrinkles, irregular pigmentation, loss of 
elasticity (elastosis) and telangiectasia (chronic dilatation of blood vessels). 
These appear in areas exposed to the sun, such as the face, neck and the upper 
extremities. Histopathological alterations in photodamaged skin have been found 
in papillary dermis: the degradation and disorganization of type collagen I, an 
increase of the collagen III to collagen I ratio, an accumulation of abnormal 
elastin, as well as an increase of glycosaminoglycans and telangiectatic vessels 
(Seite et al. 1998). The histological hallmark of photoaging, called solar elastosis, 
is the massive accumulation of atypical elastotic material in the upper and middle 
dermis. It has been suggested that elastosis results from the effects of UVR on 
cytokine expression (Kondo 2000) and on mast cells (Gonzalez et al. 1999) that 
both stimulate elastin production from ﬁbroblasts. UVR also accelerates the 
secretion of matrix metalloproteinase (MMP), which leads to the degeneration 
of the collagenous meshwork into the elastotic masses (Koivukangas et al. 
1994; Fisher et al. 1997). UV-induced cytokines and growth factors promote 
the growth of keratinocyte, resulting in hyperplasia and epidermal thickening 
(Kondo 2000). 
Although UVB radiation is mainly responsible for sunburn, UVA rather 
than UVB is considered a major factor in the process of skin photoaging due to 
the increased penetration of UVA into the dermis. Chronic UVA exposure has 
been shown to cause epidermal hyperplasia, collagen changes, stratum corneum 
thickening, Langerhans cell depletion and dermal inﬂammatory inﬁltrates 
(Kligman & Gebre 1991; Lavker et al. 1995a; Lavker et al. 1995b). UVA is known 
to induce a mitochondrial mutation called ‘common deletion’, which is present 
in high amounts in the dermis of photoaged skin (Krutmann 2000). In addition, 
UVA induces matrix metalloproteinases (Wlaschek et al. 1995; Wlaschek et al. 
1997), leading to the formation of wrinkles. 
1.1.4 UV-induced molecular changes
1.1.4.1 Pyrimidine dimer formation
UV has the capacity to initiate skin carcinogenesis through DNA damage. 
DNA absorbs UVR maximally at wavelengths of 245 to 290 (Matsumura & 
Ananthaswamy 2004). This induces covalent DNA lesions that occur most 
frequently in tandem pyrimidine bases (Tornaletti & Pfeifer 1996). Cyclobutane 
pyrimidine dimers (CPD) are formed between thymine (T) and cytosine (C) 
residues, whereas pyrimidine (6–4) pyrimidone photoproducts are formed 
among adjacent pyrimidine residues. CPDs are produced three times as often 
as (6–4) photoproducts (Pfeifer et al. 2005). Methylated CPDs rather than 6–4 
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photoproducts or other lesions, are considered responsible for the majority of 
mutations induced by UVB (You et al. 1999; You et al. 2001). The yield of (6–4) 
photoproducts is several folds lower than the yield of CPDs, and they are repaired 
more efﬁciently than CPDs are (Ichihashi et al. 2003).
At longer UV wavelengths, the yield of pyrimidine photoproducts decreases 
since DNA absorbs weakly wavelengths above 320 nm. However, UVA has been 
demonstrated to have the capability of causing pyrimidine dimers in cell cultures 
(Rochette et al. 2003;Douki et al. 2003;Courdavault et al. 2004) and in human 
skin (Freeman et al. 1987; Burren et al. 1998; Young et al. 1998b), as summarized 
in Table 1. 
1.1.4.2 Oxidative DNA damage
Despite the ability of  UVA to induce pyrimidine dimers to some extent, CPD 
formation is not the characteristic hallmark for UVA wavelengths (Berg et al. 1995). 
The genotoxicity of UVA occurs mainly through an indirect photosensitization 
process via the generation of reactive oxygen species (ROS) that are capable of 
inducing oxidative DNA damage (Cadet et al. 2005; Pfeifer et al. 2005). UVA-
induced singlet oxygen (1O2) and hydrogen peroxide are generated through the 
photoactivation and excitation of endogenous chromophores such as riboﬂavin, 
phorphyrins, quinones and pheomelanin (Klotz et al. 2001; Marrot et al. 2005). 
The reactive oxidative compounds have been shown to target DNA base guanine, 
producing 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-OHdG) within a strand of DNA 
(Kvam & Tyrrell 1997). Kvam and Tyrrell have demonstrated that 8-OHdG is 
induced in human skin ﬁbroblasts by monochromatic radiation ranging from 
a UVB wavelength of 312 nm up to wavelengths in the near visible light (434 
nm) (Kvam & Tyrrell 1997). UVA wavelengths above 334 nm were responsible 
for almost all of guanine oxidation and the authors concluded that especially 
UVA, rather than any other UV wavelength, contributed to the oxidative DNA 
damage observed in non-melanoma and melanoma skin cancers. UVA-induced 
oxidative DNA damage has also been shown by Zhang et al., who have found that 
the relative yield of 8-OHdG to pyrimidine dimers increases nearly 1000-fold in 
UVA-irradiated cells when compared with cells subjected to either UVC or UVB 
exposure (Zhang et al. 1997). In addition to the in vitro models, UVAI and II have 
been shown to induce high levels the 8-OHdG in human skin) (Table 1). 
UVR also causes other oxidative DNA damage, such as protein-DNA cross-
links and single-strand breaks (Peak et al. 1991; Peak & Peak 1991). Interestingly, 
DNA strand breaks and DNA-protein cross-links are more characteristic for 
UVA radiation than for the UVB (Matsui & DeLeo 1991; Tyrrell 1996). Finally, 
both UVA and UVB have been found to induce chromosomal instability through 
oxidative damage  (Phillipson et al. 2002; Dahle & Kvam 2003). 
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1.1.4.3 UV-induced signature mutations
Despite the ability of cells to repair UV-induced DNA lesions, some damage 
will remain unrepaired. UVB mutagenesis is characterized by a high frequency 
of mutations in the DNA sequences containing CPDs and (6–4) photoproducts 
leading to GC to AT transversions. These lesions, C to T point mutations/
transitions, and especially CC to TT tandem mutations, are considered as 
UVB signature mutations (Matsumura & Ananthaswamy 2004; Melnikova & 
Ananthaswamy 2005). 
Table 1. UVA-induced genotoxic markers.
Examined Cells Reference 
DNA damage   
Cyclobutane 
dimers 
CHO cells, human 
fibroblasts and 
keratinocytes, human skin 
 
Freeman et al 1987, Burren et al 1998, 
Young  et al 1998a, Douki et al 2003, 
Rochette et al 2003, Courdavault et al 
2004  
8-OHdG Human fibroblasts, Calf 
thymus DNA and HeLa 
cells, human skin 
Kvam and Tyrrell 1997, Zhang et al 
1997, Liardet et al 2001 
 
Protein DNA-
cross links, 
single-strand 
breaks 
Human epithelioid cells 
and XP cells 
Peak and Peak 1991, Peak et al 1991 
Chromosomal 
instability 
Keratinocytes and 
hamster fibroblasts 
Phillipson et al  2002, Dahle and Kvam 
2003 
Mutations   
GC to AT 1 Mouse SCC tumors van Kranen et al 1997 
GA to TC2 Mouse embryonic 
fibroblasts 
Besaratinia et al 2004 
AT to CG 3 CHO cells,  human AK and 
SCC tumors  
Drobetsky et al 1995, Agar et al 2004 
p53 effects4   
p53 increase Mouse and human skin de Laat et al 1997a, Burren 1998 
cell cycle 
arrest 
Fibroblasts, mouse skin de Laat et al 1996 &1997a 
p53 mutation Mouse SCC, human 
keratinocytes, human AK 
and SCC 
van Kranen et al 1997, Persson et al 
2002, Agar et al 2004 
1 UVB fingerprint 
2 8-OHdG related 
3 UVA fingerprint 
4 Discussed in the chapter 1.1.6.1 
24
STUK-A216
UVA has been found to induce mutations at AT base pairs more frequently 
than by UVB (Robert et al. 1996). The high incidence of AT to CG transversions 
established this base change as a  molecular ﬁngerprint or a signature mutation 
to UVA (Drobetsky et al. 1995). Recently, this transversion of AT to CG was found 
in the epidermal basal layer stem cells in the human squamous cell carcinoma 
and actinic keratose (Agar et al. 2004) (Table 1).
The mutational speciﬁcity of UVA is distinct from that of UVB because 
the initiating type of damage, i.e. ROS-mediated base injury, is different. UVA-
induced oxidative base damage, 8-OHdG, has been shown to generate G to T and 
A to C transversions (Cheng et al. 1992; Besaratinia et al. 2004). However, when 
assessing the impact of ROS on the induction of oxidative base damage-related 
mutations, it is difﬁcult to deﬁne which particular oxidative base change has been 
caused by a particular free radical. Consequently, it is not possible deﬁnitely to 
determine which mutation has been caused by UVA and which has been caused 
by UVB-induced ROS. 
1.1.5 UVA-induced cellular effects 
UVB radiation for long time has been considered the more harmful part of 
the UV spectrum due to its DNA-damaging potential and carcinogenic effects. 
Recently published studies have demonstrated that UVA radiation can modulate 
a variety of biochemical processes and cause severe oxidative damage via ROS 
generation. Besides an elicitation of oxidative DNA damage, oxidative stress 
also plays a crucial role in modulating gene and protein expression as well as 
in damaging membranes and inducing apoptosis. Although cells have the free 
radical scavenging systems, high levels of ROS and reactive oxygen intermediates 
can overwhelm normal defense mechanisms leading to permanent damage. UVA 
also induces the expression of several soluble factors such as proteins and lipid 
mediators that mediate inﬂammation; they may also promote tumorigenesis. 
1.1.5.1 Oxidative stress and apoptosis
The deleterious effects of UVA on lipids and proteins are mediated through 
singlet oxygen formation (Bose et al. 1990; Vile & Tyrrell 1995) (Table 2). Low 
doses of UVA radiation have been shown to induce lipid peroxidation in the cell 
membranes (Bose et al. 1990; Punnonen et al. 1991; Gaboriau et al. 1995). The 
singlet oxygen upregulates the expression of heme oxygenase (HO-1) (Keyse 
et al. 1990; Basu-Modak & Tyrrell 1993), catalyzing heme breakdown into 
iron, CO and biliverdin. HO-1 is considered a marker of the oxidative stress in 
mammalian cells and it is believed to serve as a long-term protective and defense 
mechanism against oxidative damage (Applegate et al. 1991). However, cell 
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overexpressing HO-1 have also been demonstrated to be hypersensitive to UVA, 
since temporarily increased HO-1 activity apparently releases iron from heme 
and sensitizes the cells to iron-derived-oxidative stress (Kvam et al. 2000). UVA 
also increases the level of ferritin, which is considered another adaptive response 
that protects cells by iron-catalyzed free radical reactions (Vile & Tyrrell 1993; 
Table 2. UVA-induced ROS/singlet oxygen-mediated cellular effects.
Examined Cells Reference 
Oxidative 
stress 
  
HO-1 gene 
upregulation 
Fibroblasts, 
epidermoid 
carcinoma cell line 
Keyse et al 1990, Soriani et al 1998 
 
CL100 gene 
upregulation1
Fibroblasts Keyse and Emslie 1992 
Membrane 
damage 
Fibroblasts,  
keratinocytes 
Bose et al 1990, Punnonen et al 1991, 
Gaboriau et al 1995,  Vile and Tyrrell 1995 
Ferritin 
upregulation 
Fibroblasts Vile and Tyrrell 1993, Vile et al 1994 
Iron release Fibroblasts Pourzand et al 1999, Kvam et al 2000 
Apoptosis Mouse lymphoma 
cells, human T and 
B lymphocytes, rat 
fibroblasts  
Godar 1996 & 1999a, Pourzand et al 1997, 
Pourzand and Tyrrell 1999 
 
FasL 
expression 
T-cells Morita et al 1997b 
Bcl-2 
expression 
Rat fibroblasts, rat 
endothelial cells 
Pourzand et al 1997,  
Pourzand and Tyrrell 1999 
Adhesion 
molecules1
  
ICAM-1 
expression 
Keratinocytes Krutmann and Grewe 1995,  
Grether-Beck et al 1996 
Soluble 
mediators1
  
MMP-1 
secretion 
Fibroblasts Wlaschek et al 1994, 1995 & 1997 
Signal 
transduction 
pathways2
  
MAPK 
activation 
Fibroblasts Klotz et al 1997 & 1999 
1Discussed in chapter 1.1.5.2 
2Discussed in chapter 1.1.5.3 
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Vile et al. 1994). Interestingly, the free iron amount in human ﬁbroblasts has 
been shown to increase as a result of the UVA-induced degradation of ferritin 
(Pourzand et al. 1999).
UVA-mediated apoptosis has been shown to be induced via singlet oxygen 
formation (Godar 1996; Pourzand et al. 1997; Pourzand & Tyrrell 1999; Godar 
1999b) (Table 2). UVA triggers a mixed apoptotic mechanism including (i) an 
immediate apoptosis (0–4h) through mitochondrial membrane damage and (ii) a 
delayed apoptosis (>20h) that requires the expression of apoptotic proteins (Godar 
1996; Godar 1999a). UVA-induced singlet oxygen has also been shown to trigger 
apoptosis in human skin, inﬁltrating T-cells via the upregulation of Fas-ligand 
(Morita et al. 1997b). UVA-induced apoptosis may mediate the effectiveness of 
UVA-phototherapy, as it was suggested for the treatment of T-cell mediated skin 
diseases such as T-cell lymphoma and atopic dermatitis (Morita et al. 1997b). 
UVA may also inhibit apoptosis through the induction of antiapoptotic proteins 
such as Bcl-2 (Pourzand et al. 1997; Pourzand & Tyrrell 1999). Authors postulate 
that Bcl-2 acts as an antioxidant against the effects mediated by UVA-induced 
ROS, however preventing apoptosis. This might lead to the survival of severely 
damaged cells that possibly further lead to the mutagenesis.
1.1.5.2 Soluble mediators and adhesion molecules
UVA enhances the generation and secretion of soluble mediators and adhesion 
molecules as shown in Table 3. UVA participates in the skin inﬂammation through 
the enhanced cytokine secretion by skin cells: TNF-a, IL-1a, IL-6, IL-8 and IL-
12 (Wlaschek et al. 1993; Corsini et al. 1997; Morita et al. 1997a; Avalos-Diaz 
et al. 1999; Kondo 1999). UVA has been also shown to cause a time- and dose-
dependent induction of immunosuppressor IL-10, thus possibly mediating the 
immunosuppression along with UVB (Grewe et al. 1995). 
UVA plays an important role in photoaging and possibly in metastasis, 
modulating the release of the vascular endothelial growth factor (VEGF) and 
matrix metalloproteinases (MMPs). VEGF is essential in tumor neovascularization 
and thus, in tumor progression and metastasis. UVA is known to induce the 
expression of VEGF from ﬁbroblasts and keratinocyte-derived cell lines (Mildner 
et al. 1999; Trompezinski et al. 2000). However, in normal keratinocytes UVA 
causes a decline in the generation of VEGF (Mildner et al. 1999) and an inhibition 
of UVB-induced VEGF production (Longuet-Perret et al. 1998). The differential 
response of primary keratinocytes and autonomously growing keratinocyte-
derived cell lines suggest that VEGF secretion may offer tumor cells the advantage 
of growth over normal cells (Mildner et al. 1999). 
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Table 3. UVA effects on soluble mediators and adhesion molecules.
Examined Effect Source Reference 
Soluble 
mediators 
  
TNF-� � Keratinocytes, 
fibroblasts, 
epidermis, 
epidermoid 
carcinoma cell line 
Morita 1997a,  
Corsini 1997, 
Avalos-Diaz et al 1999  
IL-1�  and -� � Keratinocytes, 
fibroblasts 
Wlaschek et al 1994, Corsini 1997 
IL-6 � Fibroblasts, 
epidermoid 
carcinoma cell line, 
keratinocytes 
Wlaschek et al 1993, 1994 & 1997,  
Morita et al 1997a,  
Avalos-Diaz et al 1999 
IL-8 � Epidermoid 
carcinoma cell line 
Morita et al 1997a 
IL-10 � Keratinocytes Grewe et al 1995 
IL-12 � Keratinocytes Kondo 1999 
VEGF � Fibroblasts, 
keratinocyte-derived 
cell lines 
Mildner et al 1999,  
Trompezinski et al 2000 
VEGF � Primary 
keratinocytes 
Longue-Perret  et al 1998, 
Mildner et al 1999 
MMP-1 � Fibroblasts, SCC 
tumor cells 
Wlaschek et al 1994, 1995 & 1997, 
Petersen et al 1995, Soriani et al 
1998, Ramos et al 2004 
MMP-10 � SCC tumor cells Ramos et al 2004 
Adhesion 
molecules 
  
ICAM-1 � Dermal endothelial 
cells, fibroblasts, 
vascular structures, 
keratinocytes 
Heckmann et al 1994b,  
Krutmann and Grewe 1995,  
Treina et al 1996, 
Grether-Beck et al 1996 
ICAM-1 � Epidermal 
keratinocytes 
Treina et al 1996 
E-selectin � Dermal endothelial 
cells 
Heckmann et al 1994 
Integrin 
chains   
�1, �2, �5 
� Fibroblasts Tupet et al 1999 
Integrins 
�5�1, �v�3
� Melanocytes Neitmann et al 1999 
MHC I, II � Rat myeloid 
leukemia cells 
Leszczynski et al 1996 
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MMPs are known to be involved in tumor progression and metastasis by 
degrading extracellular matrix components (Matrisian 1992). UVA upregulates 
the expression of interstitial collagenase (MMP-1) (Wlaschek et al. 1994; Petersen 
et al. 1995;Wlaschek et al. 1995; Wlaschek et al. 1997; Ramos et al. 2004) and of 
stromelysin-2 (MMP-10) (Ramos et al. 2004). The MMP-induction is mediated 
via UVA-induced singlet oxygen, which activates the expression of IL-1a, IL-1b, 
and IL-6 that in turn induce MMP-1 synthesis via the autocrine loop (Wlaschek 
et al. 1994). Protein kinase C (PKC) (Petersen et al. 1995) and p38 stress kinase 
pathway (Ramos et al. 2004) have also been shown to mediate MMP-secretion 
after UVA exposure. 
Besides cytokine release, adhesion molecule expression is also one of the 
characteristic features of inﬂammation. Adhesion molecules are responsible 
for the recruitment of blood leukocytes to the inﬂammation site. They are also 
involved in metastatic cascade, mediating tumor cell adhesion to the stromal 
cells of the host. UVA-induced singlet oxygen has been shown to upregulate 
intercellular adhesion molecule-1 (ICAM-1) expression (Krutmann & Grewe 
1995; Grether-Beck et al. 1996; Krutmann 2000). A similar positive association 
between UVA and the ICAM-1 expression has also been demonstrated in cultured 
dermal ﬁbroblasts and in the vascular structures of dermis (Treina et al. 1996). 
Heckmann et al. have demonstrated that dermal microvascular endothelial cells 
are the direct target of UVA by observing the upregulation in the expression of 
ICAM-1 and E-selectin in dermal endothelial cells after UVA exposure (Heckmann 
et al. 1994). However, the controversial result demonstrated the depleted ICAM-
1 expression after UVA-exposure  in human keratinocytes (Treina et al. 1996). 
Besides the adhesion molecule expression, UVA induces the expression of major 
histocompatibility class I and II on the cell surface with simultaneous PKC 
activation (Leszczynski et al. 1996) (Table 3).
Since adhesion molecules mediate intercellular interaction, it is not 
surprising that UVA has been shown to alter the adhesive properties of cells. 
UVA increases the adhesion of endothelial cells to peripheral blood derived 
granulocytes, lymphocytes, and monocytes (Heckmann et al. 1997). UVA has 
also been shown to stimulate ﬁbroblast adhesion to collagen (Tupet et al. 1999) 
as well as melanocyte adhesion to ﬁbronectin (Neitmann et al. 1999) through 
the expression of integrins. 
1.1.5.3 Tumor promotion 
Several proteins/enzymes, whose activity is increased following the UVA radiation, 
may play a role in uncontrolled cellular proliferation and hyperplasia (Table 4). 
UVA activates the phospholipases A and C (PLA, PLC) (Hanson & DeLeo 1989; 
Hanson & DeLeo 1990; Cohen & DeLeo 1993) that stimulate the release of 
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Table 4. UVA effects that may enhance tumor promotion.
Examined Effect Source Reference 
PLC, PLA  � Human and 
mouse 
fibroblasts, 
keratinocytes  
Hanson and DeLeo 1989,  
Hanson and DeLeo 1990,  
Cohen and DeLeo 1993 
AA � Human and 
mouse 
fibroblasts, 
keratinocytes 
Hanson and DeLeo 1989,  
Hanson and DeLeo 1990, 
Cohen and DeLeo 1993 
COX � Dendritic cells, 
keratinocytes, 
fibroblasts, 
epidermoid 
carcinoma cell 
line 
Hanson and DeLeo 1989,  
Hanson and DeLeo 1990,  
Soriani et al 1998,  
Krutmann and Morita 1999,  
Bachelor et al 2002 
Prostaglandin E � Fibroblasts, 
keratinocytes 
Hanson and DeLeo 1989,  
Hanson and DeLeo 1990 
DAG � Keratinocytes 
 
Hanson et al 1989,  
Hanson and DeLeo 1989 
PKC activity � Fibroblasts, 
keratinocytes, 
rat chloroma 
cells 
Matsui and DeLeo 1990,  
Matsui et al 1994,  
Leszczynski et al 1995 & 1996 
EGF receptor 
binding 
� Fibroblasts Matsui and DeLeo 1990,  
Djavaheri-Mergny et al 1994                   
MAPK family 
members p38, 
JNK, ERK1/2 
� Fibroblasts, 
keratinocytes, 
melanocytes 
Klotz et al 1997 &1999,   
Yanase et al 2001,  
Bachelor et al 2002 
AP-1, AP-2 � Keratinocytes Djavaheri-Mergny et al 1996,  
Djavaheri-Mergny and Dupertret 
2001, Grether-Beck et al 1996 
c-Jun    � Fibroblasts Bose et al 1999, Soriani et al 2000 
c-Fos � Fibroblasts, 
keratinocytes 
Silvers and Bowden 2002,  
Silvers et al 2003 
NF-�B � Fibroblasts Vile et al 1995, Reelfs et al  2004 
 
choline compounds and arachidonic acid (AA) from the cell membranes (Hanson 
& DeLeo 1989). Arachidonic acid is further catabolized by cyclo-oxygenases 
and lipoxygenases to inﬂammatory mediators, such as prostaglandins and 
leukotrienes. UVA is also known to induce directly cyclo-oxygenase (COX) 
activity (Hanson & DeLeo 1989; Soriani et al. 1998; Krutmann & Morita 1999; 
30
STUK-A216
Bachelor et al. 2002). The above-mentioned changes are involved in UVA-induced 
inﬂammatory responses that might lead to cellular proliferation (Matsui & 
DeLeo 1991). 
UVA causes a release of diacyl glyserol (DAG) in cultured cells (Hanson 
& DeLeo 1989; Hanson et al. 1989). This event mediates PKC activation, which 
further enhances the cancer promoting effect of UVA (Matsui & DeLeo 1991). 
UVA exposure has been shown to elevate directly PKC activity (Matsui et al. 
1994; Leszczynski et al. 1995; Leszczynski et al. 1996). UVA exposure is also 
known to induce inhibition of the epidermal growth factor (EGF), binding to its 
receptor (Matsui & DeLeo 1990; Djavaheri-Mergny et al. 1994) via PKC-induced 
phosphorylation (Matsui & DeLeo 1991). Inhibition of EGF receptor binding is 
one of the earliest membrane events in the activation of the mitogenic signaling 
cascade. Taken together, PKC activation, which has been strongly linked to 
chemical tumor promotion by phorbol esters, can also be inducible by a low, 
physiologic dose of UVA, possibly promoting the development of skin cancer. 
Moreover, PKC activation and translocation to the plasma membrane has been 
shown to be involved in melanoma metastasis (Gopalakrishna & Barsky 1988; 
Rusciano 2000).
The oxidative stress evoked by UV can have far reaching implications on 
carcinogenesis by activating the intracellular signal transduction pathways, 
which might lead to enhanced cellular proliferation (Devary et al. 1992; Ichihashi 
et al. 2003). UVA-induced ROS generation has been shown to activate mitogen-
activated protein kinase (MAPKs) pathway members: extracellular signal 
regulated kinases (ERK 1 and 2), c-Jun terminal kinases (JNK) and p38 MAPK 
(Klotz et al. 1997; Klotz et al. 1999; Yanase et al. 2001; Bachelor et al. 2002). UVA-
related oxidative stress also upregulated CL100 protein tyrosine phosphatase 
(Keyse & Emslie 1992). In addition to the direct activation of protein kinases, 
UVA affected transcription factors AP-1 and AP-2 (Grether-Beck et al. 1996; 
Djavaheri-Mergny et al. 1996; Djavaheri-Mergny & Dubertret 2001) and c-fos 
and c-jun (Bose et al. 1999; Soriani et al. 2000; Silvers & Bowden 2002; Silvers 
et al. 2003). All these events might affect the proliferation, differentiation and 
progression of cells (Djavaheri-Mergny et al. 1996; Klotz et al. 1999). UVA is also 
known to activate transcription factor NFkB, which plays a pivotal role in the 
regulation of inﬂammation, infection and stress response, and it also acts as a 
proto-oncogene (Vile et al. 1995; Reelfs et al. 2004). The UVA radiation-dependent 
activation of NFkB correlates with the UVA radiation-dependent peroxidation 
of cell membrane lipids and membrane damage. NFkB expression is known to 
mediate of the survival pathway in many cells and this phenomenon is believed 
to prevent the apoptosis in UVA exposed cells (Pourzand & Tyrrell 1999).
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1.1.6 Photocarcinogenesis of non-melanoma skin cancers 
Ultraviolet radiation is the major environmental risk factor for non-melanoma skin 
cancer (NMSC) formation due to its DNA-damaging potential. SCC development 
is related to the total, life-long accumulated UV dose. SCC tumors occur most 
regularly in parts of the body exposed to the sun, such as the face, neck and 
hands. Basal cell carcinomas (BCC) does not share the same direct relation, 
but it does appear to be associated with childhood UV exposure as well as with 
intermittent, heavy exposure that leads to sunburn formation (Longstreth et al. 
1998; Armstrong & Kricker 2001).
UVB is considered a complete carcinogen involved in the initiation, 
promotion and progression of NMSC. A direct correlation between p53 mutations 
– which occur in UVB-induced pyrimidine hot spots - and the onset of human 
and mice SCC and BCC provides direct evidence for the mutagenic role of UVB 
in skin carcinogenesis (Brash et al. 1991; Ziegler et al. 1994; Ziegler et al. 1996). 
UVA is 5000 times less effective as a complete carcinogen, when compared to 
UVB (Matsui & DeLeo 1991). However, UVA has been shown to alone, or in 
combination with UVB, induce papillomas (Talve et al. 1990; Kelfkens et al. 1991; 
Kelfkens et al. 1992). It has also been shown to induce SCC in hairless mice (van 
Weelden et al. 1990; de Laat et al. 1997b). UVA is also believed to promote UVB-
induced carcinogenesis but the mechanism by which it could occur is unknown; 
possibly the mechanism is related to the UV-mediated inﬂammation (Matsui & 
DeLeo 1990; Matsui & DeLeo 1991). 
An UV-action spectrum for squamous cell carcinomas has been derived 
from experiments with hairless mice (de Gruijl et al. 1993). The action spectrum 
for NMSC development reaches its maximum at 293 nm in the UVB region, after 
which it shows a steep drop for wavelengths over 300 nm. However, another peak 
of tumor formation is observed in the UVA range at 380 nm, being 5-fold higher 
than with 350 nm (Runger 1999). The UV-action spectrum for the formation of 
pyrimidine dimers and oxidative DNA base modiﬁcations has indicated that a 
second peak in oxidative DNA damage showed up at a UVA range extending 
from UVAI region to visible light (Kielbassa et al. 1997). This might explain the 
second peak of tumor formation in the NMSC-action spectrum and the capability 
of UVA to act as a complete carcinogen, inducing SCC in mice (Runger 1999). 
1.1.6.1 UV-induced p53 mutations in NMSC
The tumor suppressor protein p53 protein plays an important role in the protection 
of tissues against extracellular stress as well as in maintaining cellular integrity. 
Accumulation of the p53 protein arrests a cell cycle at the G1 phase via induction 
of the cyclin-dependent kinase inhibitor p21Waf1/CIP1, which forms a complex with 
cyclin dependent kinases (CDKs). This allows DNA repair before its replication 
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into the S phase and it prevents the replication of such damage that might lead 
to mutagenesis and carcinogenesis. Both UVA and UVB radiation have been 
shown to induce p53 expression (Hall et al. 1993; Campbell et al. 1993a; de Laat 
et al. 1997a; Burren et al. 1998) and to inhibit DNA synthesis by arresting the 
cell cycle at the S phase (de Laat et al. 1996; de Laat et al. 1997a) (Table 1). In 
addition to cell cycle arrest, the p53 protein induces apoptosis and sunburn cell 
formation if the DNA damage is lethal (Matsumura & Ananthaswamy 2004).
Mutation in the tumor suppressor gene p53 has been found to play a 
critical role in the development of NMSC (Melnikova & Ananthaswamy 2005). 
p53 mutation appears to be an early genetic change in the development of NMSC 
(Campbell et al. 1993b; Ziegler et al. 1994), and it is found even in normal skin 
exposed to the sun (Nakazawa et al. 1994) as well as in UV-exposed mouse skin 
months before skin tumors appear (Ananthaswamy et al. 1997; Ananthaswamy 
et al. 1999). p53 mutation has been detected at high frequency (50-90%) in 
SCC, BCC (Brash et al. 1996) and in actinic keratoses (Ziegler et al. 1994). The 
predominant alterations found in these lesions have been C to T and CC to TT 
transitions at pyrimidine sites, indicating the remarkable role of UVB radiation 
in carcinogenesis (Dumaz et al. 1993; Ziegler et al. 1996). 
The causal relationship between UVA exposure, p53 mutations and the 
onset of NMSC is not as clear when compared to UVB radiation (de Gruijl 2002a; 
de Gruijl 2002b). A physiological dose of UVAI has been shown to cause oxidative 
damage-derived p53 mutations in human skin (Persson et al. 2002). Moreover, 
UVA-induced SCC in mice contains some p53 mutations, however they occur at 
the UVB pyrimidine hot spots (van Kranen et al. 1997). Finally, Agar et al. have 
shown that UVA is able to induce UVA-speciﬁc signature mutation in the p53 
gene in the basal cell layer in human SCC and AK samples (Agar et al. 2004) 
(Table 1). 
1.1.7 Ultraviolet radiation induced immunosuppression 
The carcinogenic potential of UV radiation is associated with its ability to suppress 
the cell-mediated immune responses. Primarily, this prevents the development 
of excessive inﬂammation and thus, further damage to skin. However, at the 
same time UV-induced immunosuppression may comprise a major risk factor 
for the development of skin cancer by allowing cancer cells to escape from the 
immunosurveillance (Longstreth et al. 1998; Ullrich 2005). 
The antigen presentation by antigen presenting cells (APCs) to T-cells forms 
the ﬁrst step of a normal primary immune response. The contact hypersensitivity 
(CHS) reaction is initiated by epicutaneous application of a known allergen/
contact sensitizer. Langerhans cells (LCs) and macrophages catch foreign 
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material, e.g. hapten, migrate to the draining lymph nodes (DNLs) and activate 
naïve T lymphocytes, which elicits and initiates the ﬁnal immune response. 
CHS elicitation can be used when studying and determining UV-mediated 
immunological responses (Schwarz 2002). Exposure to UV-radiation results in 
a signiﬁcant decline in the number and morphology of cutaneous APCs, thereby 
impairing their antigen-presenting activity in the lymph nodes to the T-cells, 
leading to immunosuppression. UVR induces two kinds of immunosuppression, 
local and systemic (Kelly et al. 1998). Local immunosuppression refers to a 
situation where the sensitizing agent/hapten (e.g. allergen) is applied directly 
to the UV-exposed skin area after irradiation. In systemic immunosuppression, 
one area of skin is exposed to UV and the distant, non-exposed site is sensitized 
with hapten (Schwarz & Schwarz 2002; Schwarz 2002).
1.1.7.1 Local and systemic immunosuppression
The initial step in the UV-induced formation of the local immunosuppression 
is a change in the ability of Langerhans cells to present the antigen to T-cells. 
UV exposure decreases the number of LCs in the skin and downregulates the 
expression of the MHCII antigen and co-stimulatory molecules on the cell surface 
(Toews et al. 1980; Aberer et al. 1981; Weiss et al. 1995). Normal LCs present 
antigens equally for both T helper cell subclasses Th1 and Th2, but UV-irradiated 
LCs present antigen efﬁciently only to Th2 cells (Ullrich 1995). It enhances Th2 
cell proliferation and increases the production of immunosuppressor cyokines, 
such as IL-4, IL-5, IL-6 and IL-10, by Th2 cells. However, at the same time it 
leads to the failure of the proliferation and secretion of inﬂammation-related, 
anti-immunosuppressive cytokines (IFN-g, IL-12) by Th1 cells (Ullrich 1995). 
UV-altered Langerhans cells have failed to generate the contact 
hypersensitivity response in mice after contact with allergen sensitization 
(Toews et al. 1980). Moreover, the resensitization of mice with the same hapten 
again caused failure in CHS response (Toews et al. 1980). The mechanism by 
which the unresponsiveness is formed in the resensitized mouse is called the 
tolerance induction. It involves the formation of the antigen-speciﬁc suppressor 
T-cells found in the lymph nodes of UV-irradiated, hapten sensitized mice (Elmets 
et al. 1983). The detailed mechanism by which these regulatory cells suppress 
the induction of immune responses remains to be determined. However, it is 
known that one class of these suppressor/regulatory T cells express on their 
surface the cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) that appears 
to be important: hapten-speciﬁc tolerance was abrogated and the transfer of 
immunosuppression was inhibited by using a (neutralizing) antibody against 
CTLA-4 (Schwarz et al. 2000; Schwarz 2002). Antigen-speciﬁc T-suppressor cells 
are known to secrete immunosuppressive cytokines, such as IL-10, upon antigenic 
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stimulation and to increase the immunosuppressive effect of UV (Schwarz & 
Schwarz 2002). 
Cytokines released by UV-exposed keratinocytes, such as IL-10, TNF-a, 
calcitonin-gene related peptide a-MSH and NO, affect the APC functions in the 
skin, preventing inﬂammatory effects. This UV-related phenomenon is employed 
on UV-derived phototherapies (Krutmann 1998; Krutmann & Morita 1999). IL-
10 is considered to have a major role in immunosuppression by decreasing the 
number of dendritic cells as well as by complicating the antigen presentation of 
APC to the Th1 cells (Shreedhar et al. 1998; Ullrich 2005). TNF-a decreases the 
dendricity of LCs, changing their appearance to a more globular form (Vermeer 
& Streilein 1990). This prevents LC migration to the lymph nodes and antigen 
presentation to T cells. Calcitonin gene-related peptide has been shown to 
suppress the antigen presentation capability of LCs after UV exposure, inducing 
IL-10 expression (Scholzen et al. 1999; Kitazawa & Streilein 2000). UV-induced 
a-MSH inhibits the release of proinﬂammatory cytokines by Th1-cells and 
activates the keratinocytes to release IL-10 (Grabbe et al. 1996). Nitric oxide (NO) 
might be responsible for solar-simulated radiation-induced immunosuppression, 
inducing a loss of dendritic cells in the epidermis (Kuchel et al. 2003).
In systemic immunosuppression, UV induces failure in the elicitation of 
CHS when an unexposed skin site is sensitized with hapten. This phenomenon is 
due to the keratinocyte-derived release of immunosuppressive soluble mediators 
into the circulation; for example, prostaglandin E2 (Shreedhar et al. 1998), 
TNF-a (Rivas & Ullrich 1994), IL-10 (Rivas & Ullrich 1992; Ullrich 1994). IL-12 
and IFN-g have opposite effects in immunosuppression when compared to IL-10 
(Schwarz & Schwarz 2002; Schwarz 2002). IL-12 injection before UV-exposure has 
been shown to prevent UV-induced local and systemic immunosuppression as 
well as hapten-speciﬁc tolerance (Schmitt et al. 1995; Schwarz et al. 1996). The 
mechanism mediating this event might be the decline of  IL-10 and of TNF-a 
secretion by ﬁbroblasts and keratinocytes after IL-12 application (Schmitt et 
al. 2000; Werth et al. 2003), as well as the IL-12-mediated DNA repair (Schwarz 
et al. 2002). UVR-induced cellular and molecular event that that mediate the 
formation of immunosuppression are summarized in Table 5. 
1.1.7.2 Molecular targets mediating UV-induced immunosuppression
Urocanic acid (UCA) (Norval 1996) and DNA (Kripke et al. 1992) comprise 
the major molecular chromophores in the skin that mediate UV-induced 
immunosuppression (Table 5). UVB is found to isomerize trans-UCA in the 
epidermis to a more soluble cis-isomer, which has been found in UV-irradiated 
mice serum (Moodycliffe et al. 1993). Cis-UCA is able to mimic many of the effects 
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of UV exposure. It decreases the number of Langerhans cells in the skin and 
impairs their antigen presentation that is followed by the immunosuppression 
(De Fabo & Noonan 1983; Kondo et al. 1995). 
DNA damage has been shown to decrease immune responses through 
keratinocyte-derived IL-10 and TNF-a secretion (Nishigori et al. 1996; O’Connor 
et al. 1996; Nishigori et al. 1998). However, when DNA damage was repaired, the 
UV-induced immunosuppressive reactions were abrogated in the mouse (Kripke 
et al. 1992; Yarosh et al. 1994) and opossum models (Applegate et al. 1989). One 
mechanism behind the restored immune capacity might be the decreased number 
of the DNA-damaged, CPD-containing Langerhans cells in the lymph nodes of 
the UV-irradiated mice that restored the APC function (Vink et al. 1996).
Table 5. UVR-induced cellular and molecular events that mediate the formation of 
immunosuppression.
Examined Source Reference 
Langerhans cell 
depletion 
- Toews et al 1980,  
Aberer et al 1981 
Suppressor T-Cell 
formation 
- Toews et al 1980,  
Elmets et al 1983 
IL-10 secretion Keratinocytes,  
suppressor T-cells  
Rivas and Ullrich 1992,  
Ullrich 1994 &1995,  
Schwarz and Schwarz 2002 
TNF-  secretion Keratinocytes Vermeer and Streilein 1990,  
Rivas and Ullrich 1994 
NO secretion Human skin Kuchel et al 2003 
Calcitonin-related 
peptide secretion 
Neurons Scholzen et al 1999,  
Kitazawa and Streilein 2000 
�-MSH secretion Melanocytes Grabbe et al 1996, Scholzen et al 1999 
IL-12 decrease Th2 cells Ullrich 1995,  
Schwarz and Schwarz 2002,  
Schwarz 2002 
IFN-  decrease Th2 cells Ullrich 1995,  
Schwarz and Schwarz 2002,  
Schwarz 2002 
cis-UCA formation Epidermis De Fabo and Noonan 1983,  
Norval 1995, Kondo et al 1995 
DNA-damage Mouse  
keratinocytes 
Kripke 1992, Nishigori et al 1996 & 1998, 
O'Connor et al 1996 
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1.1.7.3 UVA-induced immunosuppression
UVA is known to suppress the local immune responses measured by CHS in 
mice and humans  (LeVee et al. 1997; Damian et al. 1999; Damian et al. 2001). 
UVA has also induced systemic immunosuppression in the C57BL/6 mice strain 
after primary UVA exposure (Byrne et al. 2002). The mechanisms for how UVA 
mediates the immunosuppressive responses might be similar to those involved 
in UVB-induced suppression. UVA is known to induce a marked decrease in the 
number of Langerhans cells (Bestak & Halliday 1996; LeVee et al. 1997; Halliday 
et al. 1998). UVA has also been shown to decrease the co-stimulatory molecule 
expression on the LC surface (Iwai et al. 1999). ROS are suggested to be involved 
in UVA-induced immunosuppression, impairing the Langerhans cell functions, 
since the antioxidant treatments with glutathione or vitamin E mitigated UVA-
induced immunosuppression (Iwai et al. 1999; Halliday et al. 2004; Halliday 2005). 
Langerhans cell depletion may also be involved in the UVA-radiation induced 
nitric-oxide release that mediates UVA-derived immunosuppression (Table 6).
Table 6. UVAa or SSRb-induced cellular and molecular events that affect immunological 
defence mechanisms.
UVA effects that mediate immunosuppression
Examined Location Reference 
Local 
immunosuppression 
Mouse, 
human 
Bestak and Halliday 1996,  
Le Vee et al 1997, Halliday et al 1998 
Systemic 
immunosuppression 
Mouse Byrne et al 2002 
Langerhans cell 
depletion 
Human and 
mouse skin 
Bestak and Halliday 1996,  
Le Vee et al 1997, Halliday 2005 
Co-stimulatory molecule  
(B7-1, B7-2 and ICAM-1) 
downregulation on  
LC surface 
Mouse 
keratinocytes 
Iwai  et al 1999 
NO secretiona,b Mousea and 
humanb skin 
aYuen et al 2002, bKuchel et al 2003  
ROS secretion Mouse Yuen et al 2002, Halliday 2004, 2005 
UVA effects that abolish immunosuppression
Examined Location Reference 
IFN-� expression Mouse skin Reeve and Tyrrell 1999 
HO-1 expression Mouse skin Allanson and Reeve 2004 & 2005 
HO-1 related CO-release Mouse skin Allanson and Reeve 2004 & 2005 
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However, controversial results concerning UVA-induced immunosuppression 
have been published. In contrast to UVA-induced primary immunosuppression, 
the re-exposure, resensitization and rechallenging of mice after 10 weeks from 
the ﬁrst dose led to immunoprotection instead of to systemic immunosuppression 
(Byrne et al. 2002). Damian et al. showed that the low-dose of UVA applied 
within three days induced local immunosuppression, but when exposure time 
was increased to 4-5 days, UVA was no longer capable of inducing signiﬁcant 
immunosuppression (Damian et al. 1999). Reeve et al. demonstrated that a 
single, suberythemic dose (37.5 J/cm2) of UVA protected mice from UVB-induced 
immunosuppression (Reeve et al. 1998). They determined that the photoprotective 
effect depended on the presence of  IFN-g (Reeve et al. 1999), HO-1 expression 
(Reeve & Tyrrell 1999) and HO-1-related carbon monoxide release (Allanson & 
Reeve 2004;Allanson & Reeve 2005). In humans, UVA has been shown to offer 
partial protection from UVB-induced immunosuppression in CHS induction (Skov 
et al. 2000). These results suggest that UVA exposure prior the UVB-exposure or 
to consecutive UVA exposures that increase the total UVA dose might diminish 
UVA-induced immunosuppression. Halliday has postulated that low doses of UVA 
may initiate the ROS production that mediates immunosuppression, whereas 
higher UVA doses stimulate production of the protective antioxidant enzymes 
such as HO-1 that might reverse UVB-induced immunosuppression through the 
antioxidant effect (Halliday 2005).
1.2 Melanoma
Cutaneous malignant melanoma (MM), the most lethal form of skin cancer, 
arises from the malignant transformation of melanocytes. MM is known for 
its poor prognosis and high resistance to medical therapy, and its lethality is 
primarily related to its ability to metastasize. The incidence of melanoma has 
increased by 3–7% per year among the Caucasian population throughout the 
world (Armstrong & Kricker 1994). Melanoma accounts for ~4% of all cancer 
cases, but it causes about 79% of all cancer deaths (Rouzaud et al. 2005). The 
increasing incidence rate of melanoma fortunately seems to exceed the mortality 
rate, apparently because of the early detection of melanoma lesions, which are 
curable through surgery.
The development of melanoma is a multistep process. As in all cancers, 
genetic and environmental factors participate in the onset of MM. Studies 
with melanoma families have identiﬁed susceptibility genes predisposed to 
melanoma. The main etiological risk factor for the development of melanoma 
is UV radiation, although hereditary reasons also play a notable role in the 
progression of melanoma. As with NMSC, individuals sensitive to the sun who 
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do not tan and burn easily are at greatest risk. Pigmentary traits, such as red 
hair, fair complexion, and a tendency to freckle have been shown as risk factors 
for the development of melanoma. In addition, atypical nevi that indicates a 
general instability of cellular growth, predisposes an individual to melanoma. 
A history of previous melanoma, either individual of familial, also constitutes a 
risk factor for the development of MM (Tucker & Goldstein 2003). 
1.2.1 Genetic alterations in melanoma
Approximately 50% of the melanoma prone families have been shown the linkage 
to 9p21-22 chromosome (Cannon-Albright et al. 1992; Gruis et al. 1999). The 
germline mutations in cyclin-dependent kinase inhibitor 2A gene (CDKN2A, 
INK4A/ARF) located in the chromosome 9p have been identiﬁed about in the 
20% of melanoma prone families (Cannon-Albright et al. 1992; Hussussian et al. 
1994; Gruis et al. 1999). In sporadic primary melanoma, only a few mutations 
(0-25%) and homozygous deletions (10%) are found in this gene (Ruas & Peters 
1998). However, this locus was found to carry UVB signature transversions in the 
sporadic primary melanomas, suggesting that UVB may play a role in the etiology 
of melanoma development (Pollock et al. 1995; Peris et al. 1999). The CDKN2A locus 
encodes two different tumor suppressor proteins: p16INK4 and p14ARF. The P16INK4 
protein inactivates cyclin-dependent kinases 4 and 6 (CDK4 and CDK6) and thus 
arrest cell cycle progression (Serrano et al. 1993). The majority of sporadic and 
metastatic melanomas have been shown to represent a lack in the expression of the 
gene product of CDKN2A, the tumor suppressor protein p16INK4A (Talve et al. 1997; 
Chin 2003; de Gruijl et al. 2005). If the p16INK4A protein is inactivated via mutation 
or deletion or it is not sufﬁciently expressed, a cell is incapable of arresting the 
cell cycle at the G1 checkpoint. Related to the mutations of CDKN2, a germline 
mutation in the cyclin-dependent kinases 4 gene in chromosome 12q13 has been 
found in individuals belonging to melanoma-prone families (Zuo et al. 1996). This 
mutation leads to the structural changes of CDK4. The mutated gene product is 
defective in binding to p16INK4A but holds the ability to bind cyclin D. As a result, 
CDK4 is constantly activated, thus promoting the cell cycle.
The other gene encoded by the CDKN2 locus, p14ARF, has also been shown 
to mutate in human melanomas as well in melanoma cell lines (Kumar et al. 
1998; Chin 2003). The mutation of p14ARF causes degradation of the p53 protein, 
disrupting the G1 restriction point and DNA repair. Thus far, no direct link has 
been established between the mutation of the p53 gene and melanomagenesis 
(Lubbe et al. 1994), which suggests that p53 is kept inactive via other mechanisms 
such as through the lack of the ARF protein that leads to p53 degradation (Omholt 
et al. 2003). 
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A signiﬁcant relationship between the melanocortin 1 receptor (MC1R) 
genotype and the onset of melanoma has been identiﬁed (Palmer et al. 2000; 
Kennedy et al. 2001; Rouzaud et al. 2005). 3–4 non-functional allelic variants of 
the MC1R gene have been shown to predispose individuals to a higher risk of 
skin cancer (Sturm 2002; Sturm et al. 2003), increasing the melanoma risk over 
2-fold (Palmer et al. 2000). MC1R functions as a primary regulator of eumelanin 
synthesis by binding the a-melanocyte stimulating hormone (a-MSH). Non-
functional MC1R results in the inability of melanocytes to respond to a-MSH, 
which increases the pheomelanin synthesis and which in turn contributes to 
skin carcinogenesis by producing free radicals (Rouzaud et al. 2005). Moreover, 
MC1R variants appear to increase the susceptibility of p16INK4A mutations in 
families prone to melanoma (Rouzaud et al. 2005).
Finally, mutations in the N-ras and B-raf genes in the Ras-Raf-MAPK-
signaling pathway have also been linked to the development of MM (Omholt et 
al. 2003; de Gruijl et al. 2005). Ras mutations in primary melanoma were located 
on sites regularly exposed to the sun, referring the UV-induction of this mutation 
(‘t Veer et al. 1989; van Elsas et al. 1996). The activating mutation in the B-raf 
gene has been found to occur in melanomas from intermittently exposed skin 
and rarely from unexposed or chronically exposed skin (de Gruijl et al. 2005). 
1.2.2 Development of melanoma from melanocyte to metastatic melanoma
Cutaneous melanoma can develop directly from melanocytes or from precursor 
lesions such as congenital or atypical dysplastic nevi (Herlyn et al. 1987). However, 
only approximately 50% of melanomas arise from a pre-existing nevus (Skender-
Kalnenas et al. 1995). Five stages can be distinguished in the progression of 
melanoma (Li & Herlyn 2000; Bogenrieder et al. 2003). In step 1, there is a 
common acquired or congenital nevus without dysplastic changes. Melanocytes 
have a restricted lifespan; they do not carry any genetic abnormalities and they 
depend on exogenous growth factors secreted by neighboring keratinocytes. In 
step 2, called dysplastic nevus, melanocytes show structural atypia and are 
considered as precursors of melanoma. Dysplastic lesions progress to step 3, 
the radial growth pattern (RGP) phase. In RGP, cells grow laterally but remain 
conﬁned to the epidermis, and they still depend on exogenous growth factors 
supplied by keratinocytes. In addition, cells are unable to achieve anchorage-
independent growth and thus, they are not metastatic. In step 4, cells turn to the 
more aggressive and invasive phenotype. Melanoma cells grow vertically (vertical 
growth pattern, VGP), invading the dermis and subcutaneous tissue through 
the basement membrane. In this state, cells can be characterized by genetic 
instability, anchorage-independent growth and they represent a high potential 
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for metastasis. They totally escape the proliferation control of keratinocytes and 
form connections with ﬁbroblasts, endothelial cells and the extracellular matrix. 
In VGP, melanoma cells begin to produce cytokines and growth factors in an 
autocrine manner, which enhances their autonomous growth and proliferation. 
Transition from RGP to VGP is believed to be the crucial step in the acquisition of 
metastatic phenotype and poor clinical outcome. Finally, in step 5, the melanoma 
has progressed as a fully metastatic melanoma.
1.2.3 Melanoma staging 
Melanomas have been classiﬁed into four classes according to their growth 
patterns (Friedman & Heilman 2002; Balch et al. 2003): 1) Superﬁcial spreading 
melanoma is the most common type with the radial growth phase. It occurs on 
the upper back of men and legs or on the back of women. It generally fulﬁlls the 
ABCD rule for suspicious moles: A stands for asymmetry – one half is unlike 
the other half, B is for asymmetric borders that can be irregular, diffused and 
poorly constricted, C is for varying color and D for a diameter larger than 6 
mm; 2) nodular melanoma is the second most common type of melanoma with 
the vertical growth phase. It occurs often in trunk, head and neck and has more 
serious prognosis and rapid onset possessing metastatic potential; 3) lentigo 
malignant melanoma arises in older age groups on areas exposed to the sun, 
such as on the face, head and neck region; 4) acral lentiginous melanoma occurs 
on the palms, soles and nail beds of older patients and individuals with darker 
skin types, demonstrating lateral growth. 
Melanomas are classiﬁed histologically based upon their location and stage 
of progression. Clark et al. reﬁned the microstaging of melanomas by classifying 
tumors according to the level of invasion from class I with intraepidermal location 
to the class V with invasion into subcutaneous fat (Clark, Jr. et al. 1969). Breslow 
postulated further that vertical tumor thickness might be a better indicator and 
predictor of prognosis and of metastatic capacity than the level of invasion is 
because patients with thin tumors had a longer survival rate than those with 
thick lesions did (Breslow 1970). Besides tumor depth and invasion, ulceration 
and the high vascularity of primary melanoma are poor prognostic markers. 
A clinical staging system is important in order to deﬁne patients with 
metastatic risk, to predict survival rates and to select the appropriate medical 
treatment (Lang 2002; Balch et al. 2003). The revised melanoma staging system 
by the American Joint Committee of Cancer (AJCC) categorizes melanoma 
into local (I-II), regional (III), and distant types (IV) using TNM (Tumor, Node, 
Metastasis) classiﬁcation (Balch et al. 2001). Patients without lymph node 
or distant metastases are categorized to have stage I or II disease. Class T 
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characterizes the local stage of primary melanoma and it is based on microscopic 
evaluation of the invasion and the thickness of the tumor. Patients with regional 
diseases with lymph node metastases are categorized to have a stage III disease, 
which is further subdivided into N classes based on the number of melanoma 
positive lymph nodes that are found. Patients with systemic metastatic melanoma 
at a distant body site have stage IV disease and they have been grouped into M 
classes according to the location of the metastases. 
1.2.4 Initial growth and angiogenesis
While normal melanocytes totally depend on exogenous growth stimuli, melanoma 
cells produce a large repertoire of autocrine growth factors and their receptors 
(Lazar-Molnar et al. 2000). Thus, melanoma is able to proliferate autonomously 
and to stimulate its own migration. Several paracrine growth factors produced 
by melanoma cells are targeted to host stroma. Upon activation, endothelial 
cells, ﬁbroblasts, keratinocytes and inﬂammatory cells start to secrete feedback 
substances (Lazar-Molnar et al. 2000; Li et al. 2003). All these factors act in concert 
by modulating the microenvironment to beneﬁt tumor growth, angiogenesis, 
invasion and eventually metastasis.
One critical aspect in the progression of melanoma to the more aggressive 
phenotype is neovascularization. In the absence of neoangiogenesis, a primary 
tumor cannot grow beyond the size of 1-2 mm3 because the normal stromal 
vasculature is incapable of supporting tumor growth due to the lack of 
supply of oxygen and nutrients (Timar et al. 2001; Streit & Detmar 2003). 
Neovascularization is necessary not only for tumor development but also for 
invasion and metastasis. The rich vascularity in primary melanoma has been 
associated with poor prognosis (Graham et al. 1994).
In angiogenesis, new capillary blood vessels are generated from pre-
existing vessels. Microvascular endothelial cells are stimulated to migrate 
from their parent vessels to the perivascular stroma and to initiate a capillary 
sprout that expands to capillary structures (Liotta 1986). The direction of the 
migration is determined by angiogenic stimulus. Melanoma cells constitutively 
overexpress the three major angiogenic factors of VEGF, basic ﬁbroblasts growth 
factor (bFGF) and IL-8 when compared to normal melanocytes (Lazar-Molnar et 
al. 2000). bFGF is obligatory for melanoma growth and survival and it has been 
detected in primary invasive and metastatic lesions, whereas it is not expressed 
by normal melanocytes. It also acts as a strong mitogenic factor for ﬁbroblasts 
and endothelial cells (Li et al. 2003), inducing VEGF expression from endothelium 
(Srivastava et al. 2003). VEGF, also known as a vascular permeability factor, is 
regarded as the major angiogenic stimulator under physiological and pathological 
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conditions. It promotes melanoma growth and invasiveness. The increase in the 
VEGF expression correlates with melanoma thickness and indicates the transition 
from radial to vertical growth (Velasco & Lange-Asschenfeldt 2002; Streit & 
Detmar 2003). bFGF and VEGF secretion from melanoma cells can also induce 
MMP secretion by endothelial cells, which further enhances tumor invasion to the 
surrounding tissue (Velasco & Lange-Asschenfeldt 2002). IL-8 has been shown 
to play an important role as a multifunctional cytokine in the development of 
melanoma in that it stimulates melanoma proliferation and correlates with the 
metastatic potential (Singh & Varney 2000), possibly through the IL-8-mediated 
upregulation and the activation of MMP-2 (Luca et al. 1997). 
Although many primary tumors are highly vascular, the vessels are not 
exactly identical to normal vessels, having differences in cellular composition 
and permeability. The concept of vasculogenic mimicry describes the ability of 
aggressive melanoma cells to mimic the capability of the embryonic cell to form 
tubular structures that facilitate tumor perfusion (Maniotis et al. 1999; Seftor 
et al. 2002; Hendrix et al. 2002; Hendrix et al. 2003). In vasculogenic mimicry, 
highly patterned vascular networks are composed by extracellular matrix and 
tumor cells that line the venules instead of the endothelial cells. Moreover, the 
activation and generation of endothelial associated genes, proteins and signaling 
pathways, such as vascular endothelial-cadherin (VE-cadherin), laminin and 
epithelial cell kinase , underlies the capability of melanoma to form these tubular 
structures (Seftor et al. 2001; Hendrix et al. 2001).
1.2.5 Melanoma metastasis 
Melanoma is characterized by high risk of hematogeneous metastases in the early 
stages of disease and it is the major reason for melanoma mortality. The risk of 
metastasis formation increases with the thickness and ulceration of a primary 
tumor (Gershenwald et al. 2003). Metastasis may have occurred at the time of 
initial diagnosis and thus, melanoma might have been disseminated widely and 
metastatic lesions can be fairly large (Fidler & Hart 1982). Melanoma metastases 
are often located on the skin and in lymph nodes, in the visceral organs (e.g. 
lungs and liver), and in the brains. The biological heterogeneity of primary and 
the metastatic lesions may impair medical treatment (Fidler & Hart 1982; Fidler 
1990). Due to the different genetic, biochemical and immunological phenotypes of 
tumor cells, the sensitivity and response to therapeutic agents differ within the 
primary and metastatic neoplasm and even within secondary neoplasms (Fidler 
& Hart 1982; Fidler 1990). Furthermore, the host organ environment modiﬁes 
the response of a tumor cell to systemic therapy, thus altering the efﬁciency of 
medical treatment.
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The metastatic process is a cascade of interrelated steps between tumor 
cell and host (Fidler & Hart 1982; Liotta & Stetler-Stevenson 1991). Tumor cells 
must dissociate from the primary tumor, invade the host stroma, intravasate 
to local microvessels and disseminate in circulation. They have to arrest at the 
capillary bed of the host organ, invade through the vessel wall and extravasate 
into the parenchyma, and ﬁnally to proliferate to form a new colony (Figure 3). 
Metastasizing tumor cells must overcome the immunological defense mechanisms 
of the host. The whole cascade makes metastatic dissemination a highly selective 
process and only a small subpopulation of cells is capable of completing all the 
steps necessary for colonization to distant sites (Figure 3) (Fidler & Hart 1982; 
Liotta & Stetler-Stevenson 1991). 
Figure 3. Metastatic cascade (adapted from Timar et al 2001).
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1.2.5.1 Invasion
Invasion begins with the escape of single tumor cells or small cell clusters from 
the primary tumor mass. After dissociation, tumor cells invade the surrounding 
extracellular matrix (ECM) and form interactions with the ECM components 
using speciﬁc cell surface adhesion molecules (Liotta 1986; Liotta & Stetler-
Stevenson 1991; Liotta et al. 1991). After anchorage, tumor cells start to secrete 
proteases by themselves or agitate the stromal cells to produce them. Highly 
controlled degradation of the matrix component occurs in a localized region close 
to the tumor cell surface. Tumor cell locomotion in partially degraded ECM is 
a tightly regulated process of repeated detachment and adhesion to the matrix 
components and the rearrangement of the cytoskeleton. Melanoma motility is 
regulated by motility and scatter factors secreted by melanoma cells, but the 
direction is also inﬂuenced by host-derived chemoattractants. The invasion 
across the basement membrane at the dermo-epidermal junction and in the 
vessel wall enables the melanoma cell access to lymph and blood vessels for 
further dissemination. 
The invasion involves a tightly controlled balance between substrate-
speciﬁc proteases and their inhibitors. The different proteolytic enzyme families in 
this process comprises MMPs, the plasminogen activator system, and aspartyl and 
cysteine proteases (Kurschat & Mauch 2000). Proteases degrade a broad spectrum 
of matrix components, such as collagens, gelatins, ﬁbronectin, proteoglycans and 
laminin (Edward & MacKie 1993). Melanoma cells express several MMPs, such 
as MMP-1,-2,-9,-13, membrane type 1-MMP (MT1-MMP) as well as their tissue 
inhibitors TIMP-1, -2, and -3 (Hofmann et al. 2000b). In melanoma metastasis, 
increased expression of MMP-1, MMP-2,  MMP-9 and MT1-MMP have been 
shown to correlate with an invasive phenotype (Hofmann et al. 2000b). MT1-MMP 
and MMP-2 have been shown to be localized in the tumor-stroma interface in 
metastatic lesions (Hofmann et al. 2000c). MMPs can also be used as a prognostic 
marker for the development of melanoma (Vaisanen et al. 1996). For example, 
the secretion of MMP-2 in primary melanoma correlates with hematogeneous 
metastasis (Vaisanen et al. 1998). The high serum levels of soluble MMP-1 and 
MMP-9 have a clinical value in identifying patients at high risk of the progression 
of  melanoma (Nikkola et al. 2002; Nikkola et al. 2005).
1.2.5.2 Dissemination in the circulation and extravasation
The dissemination of metastasizing melanoma cells occurs through transportation 
via lymph or blood vessels (Fidler 2003). Intravasating tumor cells enter the 
vessel lumen through the surrounding basement membrane, forming non-
destructive interaction with the endothelial cells (Timar et al. 2001). Thereafter, 
the tumor cells either grow at the penetration site or circulate as individual cells 
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or tumor emboli (Fidler & Hart 1982). In the circulatory system, melanoma cells 
have to escape from immunological and non-immunological defense mechanisms 
(e.g. blood turbulence). To increase the survival, tumor cells build a mechanical 
defense by forming aggregates with each other (homotypic aggregation) or 
with platelets or lymphocytes (heterotypic aggregation). Melanoma cells also 
initiate clot formation with ﬁbrin and platelets that not only enhances the 
survival of melanoma but also facilitates the arrest of the enlarged emboli in the 
microcapillaries of the host organ (Timar et al. 2001). Despite tumor cell evading 
mechanisms, the intravascular death of disseminated tumor cells is high and 
only 0.01% of circulating cells survive to initiate the metastatic colony (Liotta 
& Stetler-Stevenson 1991; Liotta et al. 1991; Fidler 2003). 
The direction of the disseminating tumor cell is inﬂuenced by organ-derived 
chemoattractants in the organ selective homing process (Fidler 2003). The “seed 
and soil theory” proposed ﬁrst by Paget in the 19th century suggested that the 
attraction of one type of cancer cell (seed) to certain host organs (soil) is not 
random, and different organs provide the optimal growth conditions for certain 
cancers (Paget 1889). Nowadays, it is known that the certain combinations of 
chemokines and their receptors and adhesion molecules play an important role 
in organ-speciﬁc metastatic cascade, thus determining the ﬁnal destination of 
metastasizing tumor cells (Murphy 2001). Melanoma cells have been found to 
express the chemokine receptors 7 (CCR7) and 10 (CCR10) whereas skin and 
lymph nodes, which are major metastatic sites of melanoma, express ligands 
for these receptors (Muller et al. 2001).  In addition, chemokines such as IL-8, 
melanoma growth stimulating activity (MGSA), and the monocyte chemotactic 
protein-1 (MCP-1) have been proposed as the chemokines associated with 
melanoma metastasis (Payne & Cornelius 2002).
The arrival of tumor cells to the capillary bed of a host organ is followed 
by cell arrest in the microvasculature. Besides mechanical ﬁltering, tumor cells 
form a ﬁrm adhesion with the endothelium by expressing similar cell adhesion 
molecules to leukocytes, thus mimicing the leukocyte homing process (Timar et 
al. 2001; Fidler 2003). This is an efﬁcient primary selection mechanism because 
the endothelium expresses such adhesion molecules that ﬁt to the metastasizing 
melanoma cell phenotype. After melanoma adhesion to the endothelium, the 
retraction of adjacent endothelial cells exposes the underlying subendothelial 
matrix. Using protrusions, pseudopods, melanoma cells penetrate the endothelial 
cell junction and became intercalated by endothelial cells (Sandig et al. 1997). 
The melanoma transmigration through the endothelium, i.e. diapedesis, 
involves many multiple steps of adhesive interactions between melanoma and 
endothelium. Several adhesion molecules, such as VE and N-cadherins, integrin 
avb3 and adhesion molecule L1 have been shown to be involved in a highly 
46
STUK-A216
restricted manner in the diapedesis (Voura et al. 1998a; Voura et al. 2001). 
After extravasation, tumor cells have to accommodate to the new organ-speciﬁc 
environment of the subendothelial matrix. The successful growth of the secondary 
neoplasm involves the proper response to organ-speciﬁc factors. Those tumor 
cells incapable of adjusting their phenotype to the new tissue parenchyma will 
die; however, cells with a potential to proliferate and express growth factor 
receptors for those present in the host organ will survive and initiate a new 
colony formation (Timar et al. 2001; Fidler 2003). 
1.2.5.3 Adhesion molecules involved in metastasis 
Several adhesion molecule families are involved in melanoma metastasis. 
Adhesion molecules mediate the melanoma attachment to extracellular matrix 
components, thus enhancing melanoma migration in ECM as well as in skin 
capillaries during intravasation and extravasation (Johnson 1999; McGary et al. 
2002). Adhesion molecules are also required in the positioning of MMPs on the 
cell surface. For example, the expression of activated MMP-2 and MT1-MMP has 
been shown to correlate with the expression of avb3-integrin in the invasive or 
metastatic melanomas  (Hofmann et al. 2000a; Hofmann et al. 2000b). Adhesion 
molecules cooperate with receptor tyrosine kinases to activate proliferation 
and survival pathways: Signaling through integrin avb3 occurs via the MAPK 
proliferation pathway, whereas Mel-CAM affects through the antiapoptotic 
survival AKT/protein kinase B-mediated pathway (Perlis & Herlyn 2004). Li et al. 
have shown that the hepatocyte growth/scatter factor (HGF/SF), which is known 
as a potential melanocyte and melanoma mitogen, downregulates E-cadherin 
expression in melanocytic cells through its receptor c-met and the subsequent 
signaling pathway, MAPK (Li et al. 2001b).
1.2.5.3.1 Cadherins
Cadherins form a family of cell surface glycoproteins (Takeichi 1991). They 
mediate the calcium-dependent cell recognition and adhesion of neighboring cells 
and serve as a component in the gap junctions (Takeichi 1991; Li & Herlyn 2000). 
Cadherins are involved in many physiological conditions, such as embryogenesis, 
morphogenesis and in the cell motility. In normal human skin, E (epithelial)-
cadherin is expressed on the surface of keratinocytes, melanocytes and LCs (Li 
& Herlyn 2000), whereas the VE (vascular endothelial)-cadherin is expressed by 
endothelial cells lining the vessel wall (Hendrix et al. 2001). N(neural)-cadherin 
is normally expressed by dermal ﬁbroblasts and endothelial cells but not by 
keratinocytes (Li & Herlyn 2000). P(placental)-cadherin is expressed only by 
basal keratinocytes (Li & Herlyn 2000). E-cadherin forms the functional and 
structural contact between melanocytes and keratinocytes, mediating keratinocyte 
47
STUK-A216
control over melanocyte proliferation and differentiation (Tang et al. 1994). The 
importance of this interaction has been shown in vitro: melanocytes in cell 
cultures change their phenotype in a similar manner to melanoma cells in situ by 
downregulating their E-cadherin expression followed by a concomitant increase 
in the expression of the adhesion molecules Mel-CAM and avb3 on the melanocyte 
surface (Herlyn et al. 2000). However, when melanocytes are co-cultured with the 
epidermal keratinocytes, the expression of adhesion molecules return to normal 
status, thus indicating the importance of E-cadherin and keratinocyte-mediated 
regulation (Herlyn et al. 2000; Hsu et al. 2000b).
During the progression of melanoma, a decline in E-cadherin expression 
has been shown to correlate with diminished keratinocyte-mediated control and 
with the increased proliferation of melanoma cells (Hsu et al. 1996; Danen et al. 
1996). The loss of E-cadherin on the cell surface also results in the inability of 
melanoma cells to adhere to each other through homotypic interactions within 
the primary tumor. This leads to the loosening of the primary tumor mass, 
which is accompanied with the enhanced invasive potential of melanoma cells 
as observed in RGP melanomas (Li & Herlyn 2000).
The loss of E-cadherin is followed by the increased expression of N-cadherin 
on the melanocyte surface. This shift in the cadherin proﬁle has been observed 
both in vitro (Tang et al. 1994; Hsu et al. 1996) and in vivo (Hsu et al. 1996; 
Sanders et al. 1999) and it is a well-known marker of the invasive phenotype. 
N-cadherin promotes and mediates the heterotypic adhesion of melanoma cells 
to ﬁbroblasts and enables cellular communication through gap junctions (Hsu 
et al. 2000a; Li et al. 2001a). This enhances the melanoma migration and assists 
their invasion from the epidermis to the dermis. N-cadherin also increases the 
melanoma communication with vascular endothelial cells (Meier et al. 1998; Li 
& Herlyn 2000). This improves the ability of the melanoma to intravasate as well 
as extravasate (Sandig et al. 1997; Voura et al. 1998b). The N-cadherin expression 
also appears to mediate the melanocyte survival through the activation of the 
PKB/AKT pathway leading to the subsequent downregulation of pro-apoptotic 
proteins (Li et al. 2001a).
1.2.5.3.2 Integrins 
In addition to cadherins, integrins also play an essential role in the progression 
of melanoma. Integrins are transmembrane heterodimers formed by different 
types of non-covalently linked a and b chains (Hynes 1992). The expression of 
several integrins has been shown to be involved in the progression of melanoma 
(Hart et al. 1991). Integrins a4b1 and avb3 have been shown to correlate with poor 
clinical outcome related to the invasive (avb3) and metastatic (a4b1) properties of 
melanoma cells (Albelda et al. 1990; Schadendorf et al. 1993; Danen et al. 1995; 
Van Belle et al. 1999). 
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The b3 subunit expression has been found to be a speciﬁc marker for the 
progression of melanoma from to RGP to VGP (Natali et al. 1995; Natali et al. 
1997; Hsu et al. 1998; Van Belle et al. 1999). Integrin avb3 binds to vitronectin 
and other ECM components (Montgomery et al. 1996). It is also involved in the 
formation of ﬁrm adhesion to endothelial cells that express the ligand of the avb3, 
the adhesion molecule L1 (Voura et al. 2001). Activation of avb3 has been shown 
to prevent melanoma apoptosis (Montgomery et al. 1994). avb3 also appears to 
be required for angiogenesis (Brooks et al. 1994) and for the activation of MMPs 
(Brooks et al. 1996). Through the expression of a4b1, melanoma cells may mimic 
the leukocyte homing process during transendothelial migration by interacting 
with VCAM-1 and selecting receptors in the activated endothelium (Okahara 
et al. 1994).
1.2.5.3.3 Immunoglobulin superfamily
Cell adhesion molecules that belong to the immunoglobulin superfamily have 
also been connected to melanoma metastasis (Shih et al. 1994; Johnson et al. 
1996). Mel-CAM (also known as MUC18, CD146 and L-Endo) is a cell surface 
glycoprotein that has been identiﬁed as an adhesion receptor in benign nevi and 
also in melanomas, where its upregulation correlates with tumor thickness and 
metastatic potential (Luca et al. 1993; Shih et al. 1994; Xie et al. 1997; Jean et al. 
1998). Mel-CAM plays a role in the homotypic binding between melanoma cells 
(Johnson et al. 1997), possibly enhancing cluster formation and capillary arrest 
in the circulation (McGary et al. 2002). Mel-CAM also mediates the adhesion 
between melanoma cells and endothelium (Shih et al. 1997). This may promote 
both the intravasation as well as the extravasation of melanoma cells (McGary et 
al. 2002). Furthermore, Mel-CAM has been shown to increase MMP-2 expression 
from melanoma cells (Xie et al. 1997), thus enhancing metastatic potential via 
ECM degradation. 
The upregulated expression of intercellular adhesion molecule (ICAM-1) has 
been observed in malignant melanocytic lesions (Natali et al. 1990). It correlates 
with the increased vertical thickness of primary melanoma and with poor 
prognosis (Schadendorf et al. 1993; Schadendorf et al. 1995; Natali et al. 1997). 
The serum of melanoma patients has been demonstrated to contain higher 
levels of soluble ICAM-1, correlating with disease progression (Hirai et al. 1997). 
However, the exact role of ICAM-1 in the melanoma development is unknown, 
but it might enhance aggregate formation with leukocytes in the circulation, 
thus mediating tumor cell survival (Johnson 1999). The activated leukocyte 
cell adhesion molecule (ALCAM) is also expressed by melanoma cells and its 
expression correlates with enhanced metastatic potential (Degen et al. 1998). It 
mediates, like ICAM-1, melanoma binding with leukocytes, thus helping them 
survive in the circulation.
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1.2.6 Ultraviolet radiation and melanoma
The exact role of UV in the etiology of malignant melanoma is unclear when 
compared to NMSC. Unlike NMSC, melanoma occurs in young adults. Whereas 
SCC development is linked to total lifetime exposure, the development of 
malignant melanoma is associated with intense, intermittent exposure especially 
during childhood (Longstreth et al. 1998;Autier & Dore 1998;Whiteman et al. 
2001). The location of the occurrence of melanoma provides further evidence for 
the intermittent type of exposure: melanomas occur often in areas protected 
from the sun, such as trunk in men and in the legs in women. The risk of 
melanoma is often higher for indoor workers that it is for outdoor workers. This 
can be associated with the intense intermitted type of exposure in leisure time. 
Autier et al. showed that recreational exposure, sunbathing and the number of 
holiday weeks spent annually in sunny resorts formed a signiﬁcant risk factor 
in developing melanoma (Autier et al. 1994b). Severe sunburn is a critical factor 
in the development of melanoma, especially if experienced in childhood; this is 
also supported by epidemiological studies (Whiteman & Green 1994; Holly et 
al. 1995). XP patients that face an extremely high risk of developing melanoma 
state the role of UVR as an etiological reason for malignant melanoma. 
1.2.6.1 UVR- induced molecular changes involved in melanomagenesis
1.2.6.1.1 UVR-mediated enhanced proliferation and migration
The progression of melanoma occurs through a series of steps, some of which 
might involve UVR-induced effects (Table 7). UVR induces DNA damage through 
the formation of single strand breaks (Wenczl et al. 1998; Marrot et al. 1999) 
and thymine dimers (Young et al. 1998b) that may lead to mutagenesis if they 
remain unrepaired. UVR also acts indirectly by stimulating the synthesis of 
soluble mediators by epidermal cells that mediate the proliferation and survival 
of melanocytes (Imokawa et al. 1992; Kadekaro et al. 2003; Rouzaud et al. 2005; 
Kadekaro et al. 2005). UVR-induced keratinocyte-derived endothelin (ET-1) 
and a-MSH have been shown to upregulate the expression of MC1R on the 
melanocyte surface (Scott et al. 2002), which in turn leads to enhanced melanocyte 
proliferation via the cAMP mediated pathway (Im et al. 1998). ET-1 and a-MSH 
have been shown to be mitogenic (Tada et al. 2002), “rescuing” melanocytes from 
UV-induced G1 arrest (Tada et al. 1998). They also act as pro-survival agents 
activating the Akt/PKB antiapoptotic pathway (Kadekaro et al. 2003; Kadekaro 
et al. 2005). 
UVA and UVB are known to induce cytokines, such as IL-6 and IL-8 
(Kirnbauer et al. 1991; Singh et al. 1995; Morita et al. 1997a; Krutmann 1998) 
that both mediate the autonomous growth of melanoma and serve as markers 
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for melanoma metastasis. UVB-induced keratinocyte-derived ET-1 has been 
shown to downregulate E-cadherin expression in melanocytes and melanoma 
cells (Jamal & Schneider 2002). UVR is known to downregulate E and P-cadherin 
expression directly in both melanocytes and melanoma cells (Seline et al. 1996). 
UVR also upregulates the expression of integrins in the suprabasal layer of the 
epidermis in the nevus (Tronnier et al. 1997). These UV effects on adhesion 
molecule expression might promote melanoma invasion and metastasis.
Both UVA and UVB radiation upregulate and activate the expression of 
such proteins in melanocytes that are involved in the progression and metastasis 
of melanoma. UVA has been shown to enhance the expression of proteins that 
are associated with cellular growth, vascular invasion and metastasis in the 
melanoma cell lines (Zhang & Rosdahl 2003). UVB, in turn, increases the 
expression of proteins involved in cellular proliferation (Zhang & Rosdahl 2003). 
This suggests that both UVA and UVB might contribute in the melanomagenesis, 
possibly via separate pathways leading to uncontrolled proliferation and enhanced 
migration. 
Table 7. UVR effects that might enhance the melanomagenesis.
Examined UV 
region 
Location Effect Reference 
�-MSH UVR Keratinocytes MC1R 
gene 
� 
Scott et al 2002 
ET-1 UVR Keratinocytes MC1R 
gene
� 
Scott et al 2002 
IL-6 UVA, 
UVB 
Epidermoid 
carcinoma cell line, 
keratinocytes 
� Morita 1997a,  
Kirnbauer et al 1991 
IL-8 UVA, 
UVB 
Epidermoid 
carcinoma cell line, 
melanocytes  
� Morita 1997a,   
Singh et al 2000 
�3�1- and 
�6�1-
integrins 
UVR Suprabasal 
epidermis in nevi 
� Tronnier et al 1997 
E-cadherin UVB Keratinocytes, 
melanocytes, 
melanoma cells 
� Seline et al 1996,  
Jamal and Schneider 2002 
 
P-cadherin UVB Melanocytes, 
melanoma cells 
� Seline et al 1996 
p73, Nupp UVA Melanocytes � Zhang and Rosdahl 2003 
Id1, p27 UVB Melanocytes � Zhang and Rosdahl 2003 
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Recently published studies postulate an interesting relationship between 
an overexpression of growth factors and UVB. By combining bFGF, stem cell 
factor and ET-1 with UVB, invasive melanoma lesions were shown to develop 
in newborn skin grafts whereas in adult skin, only melanoma in situ lesions 
were observed (Berking et al. 2001; Berking et al. 2004). Young skin seems to be 
very susceptible to the transforming effects of exogenous growth factors when 
combined with UVR. Noonan et al. found that a single high dose of combined 
UVB and UVA wavelengths was sufﬁcient to initiate melanoma in neonatal 
(HGF/SF) transgenic mice, but not in adult mice, even after chronic exposure to 
UVR (Noonan et al. 2000; Noonan et al. 2001). This result further supports the 
notion that UVR exposure and sunburn experienced in childhood appear to be 
a signiﬁcant risk factor for developing melanoma.
1.2.6.1.2 Melanin and UVA in melanomagenesis
A fair-skinned Caucasian population seems to be more susceptible to developing 
melanoma than people with darker skin are. This might be due to the lack of 
photoprotection, but the other possibility could be the different type of melanin, 
i.e. pheomelanin, synthesized in Caucasian skin (Diffey et al. 1995). Certain 
MC1R gene variants have been associated with red hair, fair skin, freckling 
as well as with sensitivity to the sun in Northern European and Australian 
populations (Kadekaro et al. 2003; Rouzaud et al. 2005). The observation that 
melanocytes with high pheomelanin vs. eumelanin content are more sensitive to 
UVR-induced cytotoxicity suggests that pheomelanin might have an important 
role in skin carcinogenesis (Kadekaro et al. 2003; Rouzaud et al. 2005). This is 
further supported by the notion that pheomelanin content has been observed to 
be higher in the dysplastic nevi when compared to the normal nevus (Jimbow 
et al. 1991). 
Pheomelanin is believed to act as a photosensitizing agent that reacts 
with UVA. UVA has been demonstrated to induce signiﬁcantly more single 
strand breaks (Wenczl et al. 1998) and DNA damage, like 8-OHdG (Kvam & 
Tyrrell 1999; Hill & Hill 2000), in heavily pigmented cells when compared to 
lightly pigmented cells. Moreover, Hill et al. demonstrated that although heavily 
pigmented melanocytes harbored more DNA damage, they were at the same time 
resistant to UVA-induced cell death (Hill & Hill 2000). However, unpigmented 
melanocytes have been shown to be much more susceptible to UVA-induced 
membrane permeability and lipid peroxidation than strongly pigmented cells 
(Kvam & Dahle 2003). The pheomelanin precursor, 5-S-cysteinyldopa, has been 
shown to sensitize DNA and to signiﬁcantly protect melanocytes from membrane 
damage induced by UVA (Kvam & Dahle 2004; Kvam & Dahle 2005). These 
results suggest that UVA may be a potential mutagen for cells containing 
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pheomelanin, causing single strand breaks and oxidative damage. However, 
pheomelanin may protect cells from membrane damage and cell death. This 
may enable the survival of severely DNA-damaged cells that possibly further 
lead to the mutagenesis.
1.2.6.2 Which wavelength is the most effective in melanomagenesis?
Although UVR is the main etiological risk factor for the development of 
melanoma, the precise wavelengths involved in melanomagenesis are unclear. 
Epidemiological studies cannot solely identify wavelength dependency and 
therefore, this information has to be obtained from animal studies. Two animal 
models, a marsupial and a hybrid ﬁsh, have demonstrated the possible role of 
UVA in melanoma initiation. 
The South-American opossum, Monodelphis domestica, has been used 
widely in photodermatological studies because it can repair UV-induced 
pyrimidine dimers by a visible light-activated photolyase enzyme (Jhappan et 
al. 2003). It is thus far the only non-transgenic animal model in which melanoma 
has been shown to be inducible by UV radiation alone (Ley 2002). In addition, 
UVA is capable of inducing the melanoma precursors in this opossum strain after 
prolonged exposure to broad-spectrum UVA (Ley 1997). However, these precursor 
lesions do not develop to fully potent malignant melanoma. The limitation of this 
model is that the genetics of this animal are poorly deﬁned. Moreover, the UV-
induced melanocytic precursors are dermal-derived, not epidermal as in humans 
(Jhappan et al. 2003). 
The only action spectrum for the development of melanoma has been 
obtained from studies with hybrid ﬁsh, Xiphophorus. Setlow et al. showed that 
UVA radiation was capable of inducing melanoma in the hybrid ﬁsh after a 
single, non-erythemogic exposure to monochromatic UVR (Setlow et al. 1993). 
The authors showed that 365 nm would be the most effective wavelength to 
cause melanoma in the ﬁsh. They concluded that if this data is extrapolated 
to humans, solar UVA causes over 90% of MM incidences (Setlow & Woodhead 
1994; Setlow 1999). One problem with this model is its evolutionary distance 
from mammals. Moreover, tumors do not develop from typical melanocytes and 
they do not resemble human melanomas (Jhappan et al. 2003). 
The controversial result has also been published. De Fabo et al. showed 
using the (HGF/SF) transgenic mouse model that only UVB wavelengths were 
responsible for the induction of MM, whereas UVA was found ineffective, even 
at high doses (150 kJ/m2) (De Fabo et al. 2004).
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1.2.6.3 Sunscreen use as a risk factor
The use of sunscreens has been advocated as an important way of preventing skin 
cancer. Sunscreens have been shown to protect against photoaging (Harrison et 
al. 1991) and to prevent solar keratosis (Thompson et al. 1993; Naylor et al. 1995). 
Sunscreen use is known to prevent DNA damage in humans (Bykov et al. 1998; 
Berne et al. 1998; Young et al. 2000; Liardet et al. 2001) and to abolish the frequency 
of p53 mutations and NMSC formation in mouse models (Ananthaswamy et al. 
1997;Ananthaswamy et al. 1998;Ananthaswamy et al. 1999).  These results 
suggest that sunscreens may protect well against UV(B)-related events, which 
may lead to non-melanoma skin cancer. Concerning MM, the effect of sunscreens 
is less clear. One study demonstrated that sunscreen with UVA and UVB ﬁlters 
did not prevent melanoma outgrowth in a mouse transplantation model after a 
minimal effective dose of UVB, although it completely inhibited erythema and 
reduced the formation of sunburn cells (Wolf et al. 1994). This postulates the 
notion that the protection of skin from erythema formation does not necessarily 
imply the prevention of other effects of UVR, such as immunosuppression. 
Sunscreens have failed to offer the proper protection against 
immunosuppression (Fourtanier et al. 2000; Nghiem et al. 2001; Moyal & 
Fourtanier 2002; Moyal & Fourtanier 2003). The immunoprotection factor (IPF) 
of sunscreen, determined using CHS assay after a single dose of SSR, was 
demonstrated to be about 50% less that the sun protection factor (SPF) (Kelly et 
al. 2003). Poon et al. obtained similar results by showing that the IPF does not 
correlate with the SPF but with the UVA protective capability of the sunscreens 
(Poon et al. 2003). The SPF label in sunscreens illustrates mainly its UVB 
protection capability because the SPF rating system is based on the prevention 
of erythema. However, this does not adequately assess UVA protection since UVA 
is less erythemogenic than immunogenic. It has been suggested that sunscreens, 
instead of using only SPF, should be rated according to their immune protective 
capability (IPF) in order to provide a better indication of their protection against 
UVA radiation (Poon et al. 2003). Moreover, sunscreen with high SPF has been 
shown to fail to protect properly against the production of UVA-induced free 
radicals during sunbathing (Haywood et al. 2003). The authors have shown 
that the “free-radical factor” based on their results was only 2 whereas the SPF, 
when measured using erythema as an end-point, was >20. Taken together, the 
results presented above suggest that SPF is insufﬁcient in predicting the ability 
of sunscreen to protect against UVA-induced effects. 
Several epidemiological studies have been conducted to clarify whether 
sunscreen is a risk factor for developing melanoma (Wang et al. 2001). Some 
studies have shown a positive correlation between the use of sunscreen and the 
incidence of melanoma (Autier et al. 1994a; Westerdahl et al. 1995; Wolf et al. 
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1998), whereas other studies have found no association with the use of sunscreen 
(Huncharek & Kupelnick 2002).
1.2.6.4 Sun bed use as a risk factor
During a cosmetic indoor tanning session, people submit themselves to a large 
quantity of UVA exposure. Artiﬁcial tanning in solaria has been linked to the 
development of melanoma (Westerdahl et al. 1994; Autier et al. 1994a; Westerdahl 
et al. 2000), but epidemiological studies do not provide unequivocal data about 
the association (Swerdlow & Weinstock 1998; Wang et al. 2001; Young 2004). 
The methodological limitations of retrospective case-control studies make it 
difﬁcult to make deﬁnitive conclusions: (i) the assessment of exposure is based 
on questionnaires concerning personal sun bed use and recall bias may lead to 
overestimates, especially among those participants that developed skin cancer; 
ii) exposure in a solarium is difﬁcult to distinguish from exposure from natural 
sources; iii) bias is caused by the lack of information on the spectral output of 
the lamps used in tanning devices (Wang et al. 2001). A recent Scandinavian 
prospective cohort study shows the strongest evidence thus far for a causal 
relationship between sun bed use and MM (Veierod et al. 2003). A total of 
106,379 women in Sweden and Norway were monitored for an average of 8.1 
years. There was an increased risk of MM with an OR of 2.58 (95% CI, 1.48-4.50) 
among females in the 20-29 year age group who used a sun bed more than once 
a month (Veierod et al. 2003). This result supported the previous notion that 
adolescence and early adulthood appear to be the most sensitive age periods 
for UVR exposure, either from natural or artiﬁcial sources. Melanoma is also 
associated with a high rate of mortality. Diffey has estimated that the current 
use of tanning devices in the UK results in ~6% of deaths per year (Diffey 2003). 
Taken together, the epidemiological data suggest a possible positive relationship 
between the use of solaria and the increased risk of melanoma, but the data are 
not conclusive and the additional studies are needed.
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2. Aim of the present study
A number of studies have demonstrated that UVA radiation is capable of 
damaging DNA, causing mutations, promoting carcinogenesis and it participates 
in the pathogenesis of squamous cell cancer and possibly in cutaneous melanoma. 
However, the effect of UVA on melanoma metastasis has not been studied. 
UVA radiation can modulate various cellular processes, some of which 
might affect tumor metastasis and enhance the metastatic potential of melanoma 
cells. Considering the depth of UVA penetration and its effects on the expression of 
adhesion molecules, cytokines and immunosuppression the working hypothesis in 
this study was that UVA might alter the adhesive properties of tumor cells present 
in blood circulation in skin capillaries and cause them to become more adhesive 
to endothelium and subsequently to form more metastases (Figure 4.) 
Using C57BL/6-derived mouse melanoma cell lines B16-F1 and B16-F10 
and the syngeneic endothelial MS1 cell line, in vitro experiments were executed 
to study the effect of UVA on melanoma cell adhesiveness. These results are 
described and discussed in Publication II. In Publications I and III, the main 
emphasis was on the induction of the metastasis in vivo C57BL/6 mouse model. 
This was used to determine the physiological relevance of UVA as an enhancer 
of the metastatic potential of melanoma cells and to study the mechanisms 
behind the phenomenon. Finally, studies were carried out on the effects of UVA 
on gene expression in the B16-F1 mouse melanoma cell line;  those results are 
discussed in Publication IV. 
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Extravasation to internal organ
Migration with bloodstream
Cell detachment & intravasation
UVA
Figure 4. Considering the depth of UVA penetration, the working hypothesis in this 
study was that UVA might alter the adhesive properties of tumor cells present in skin 
capillaries and cause them to become more adhesive to endothelium and subsequently, 
to form more metastases.
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3. Materials and methods
The experimental methods used in the present study are listed in Table 8. Detailed 
information and descriptions are found in the enclosed original publications and 
the references therein. Brief descriptions of the methods are presented below. 
3.1 UVA radiation source and dosimetry 
A facial tanner lamp, Philips HB 171/A was used as the radiation source. UVB 
radiation was ﬁltered with a 5-mm thick glass ﬁlter. The irradiances were measured 
at the same distance from the lamp as in the actual in vitro and in vivo UV-
exposures. The spectral irradiances were measured with a temperature stabilized 
Optronic and Bentham DM150 double-monochromator spectroradiometer at 
0.5 nm intervals from 250 nm to 400 nm. The spectroradiometer was calibrated 
against a 1000 W halogen standard lamp traceable to the National Institute of 
Standards and Technology. The spectroradiometer measurement uncertainty 
was estimated at ± 8%. 
The attenuation of the irradiance caused by the UVB glass ﬁlter in the in 
vivo experiment or by the UVB ﬁlter, dish cover and the culture medium in the 
in vitro experiments was taken into account when measuring the irradiance. The 
UV irradiance that reached the mice or the melanoma cells was 3.5-4.2 mW/cm2. 
The UV spectrum used throughout this study was 310-400 nm, from which the 
UVA portion was 99.99% and UV-B was 0.01%. When the other error sources 
Table 8. Methods used in the present study 
Methods Publication 
Cell culture I, II, III, VI 
UV dosimetry in vitro II, III, IV 
UV dosimetry in vivo I, III 
Cell viability II 
Adhesion assay between melanoma and endothelium II 
Aggregation assay between melanoma cells II 
Analysis of cadherins II 
Animals and i.v. injections I, III 
CHS assay III 
cDNA array IV 
Western blot analysis of cyclin G IV 
Cell cycle analysis IV 
The UVA transmittance through mice skin unpublished 
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during the exposure, e.g. the radiation distribution, distance, the exposure timing, 
lamp drift during individual exposure and the whole experiment, are taken into 
account, the uncertainty of the exposure dose was estimated at ± 12% for in vitro 
experiments and ±14% for the in vivo experiments.
3.2 Cell culture
These studies utilized C57BL/6 mice-derived melanoma cell lines B16-F1 (low 
metastatic potential) and B16-F10 (high metastatic potential) as well as the 
C57BL/6 mice-derived MS-1 endothelial cell line. The melanoma cell lines were 
grown in an RPMI-1640 cell culture medium and the MS-1 endothelial cell line in 
Dulbecco’s MEM cell culture medium. The cell culture media were supplemented 
with 10% heat-inactivated FBS, penicillin (100 IU/ml), streptomycin (100 µg/ml), 
and L-glutamine (4 mM). All cell culture supplies were purchased from Gibco 
BRL, Paisley, UK. 
3.3 In vitro experimental set-up
3.3.1 In vitro irradiations
The melanoma cells were irradiated in plastic Petri dishes through a 5-mm glass 
ﬁlter, the dish cover and culture medium. The B16-F1 and B16-F10 melanoma 
cells were exposed to a single dose of UVA at 2, 4, 8, and 12 J/cm2. In some 
experiments, cells were irradiated with four UVA doses of 2 J/cm2 with 1-hour 
intervals between each exposure. All irradiations were performed at room 
temperature in a dark room on a black support in order to avoid the effects of 
reﬂected radiation. The temperature of the cell culture medium did not exceed 
37ºC during irradiation. The control cells were sham-treated by keeping them 
at room temperature in a dark room. 
3.3.2 Cell viability and cell morphology assessment
The melanoma cells, both those adhering to the bottom of the culture dishes as 
well as these ﬂoating in the culture medium, were harvested with versene solution 
1, 4, and 24 hours after the end of UVA irradiation. Thereafter, the melanoma cells 
were washed once with PBS and suspended in PBS. Cell viability was assessed 
using the trypan blue exclusion method. Cell morphology and apoptosis were 
examined using cytospin cell smears stained with the standard May-Grünwald-
Giemsa (MGG) method.
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3.3.3 Melanoma-endothelium binding assay
MS-1 endothelial cells were grown in ﬂat-bottomed 96-well plates that were coated 
overnight at 4ºC with bovine collagen. Conﬂuent endothelial monolayers formed 
within 1 day after seeding and they were used in the tumor cell attachment assay. 
B16-F1 and B16-F10 melanoma cells used in the binding assay were metabolically 
labeled with 3H-thymidine for 48 hours. The 3H-thymidine labeled the semi-
conﬂuent monolayers of B16-F1 and B16-F10 melanoma cells were exposed to a 
single dose of UVA at 2, 4, 8, and 12 J/cm2. The melanoma cells were harvested 
with versene at 1, 4 or 24 hours after the end of irradiation. The adhesion 
assay between UVA-exposed melanoma cells and endothelial monolayers was 
performed using the method of Pauli and Lee (Pauli & Lee 1988). Microtiter 
plates were then incubated for 30 minutes at 37ºC to allow binding between 
both cell types. At the end of incubation, the unattached melanoma cells were 
removed by gentle centrifugation. The cells that remained in the microwells 
(endothelial monolayers with bound 3H-thymidine-labeled melanoma cells) were 
solubilized overnight at 37ºC with NaOH. The solubilized cell suspension was 
mixed with 1 ml of scintillation ﬂuid and the 3H content was measured in an 
LKB 1210 Ultrobeta scintillation counter. Each adhesion experiment was made 
in 8-12 separate microwells (replicates). 
3.3.4 Melanoma-melanoma aggregation assay
To examine the homotypic aggregation of the B16-F1 and B16-F10 melanoma 
cells, the semi-conﬂuent monolayers of the B16-F1 and B16-F10 cells were 
exposed to a single UVA dose at 8 J/cm2 or to fractionated dose of 4 x 2 J/cm2. 
Cells were harvested using versene at 1, 4, and 24-h after the end of irradiation, 
washed twice with culture medium and re-suspended in culture medium at a 
concentration of 1x106 cells/ml. Aliquots of 500 µl/well of a single-cell-suspension 
were placed in 24-well plate and incubated for 60 minutes at 37ºC on a rotary 
shaker slowly rotating at 78 rpm. Thereafter, the cells were gently aspirated 
from the wells and number of single cells and cell aggregates were counted in 
microscope using haemocytometer. 
3.3.5 Flow cytometry analysis of cadherin expression
For the ﬂow cytometry analysis of cadherins expression, the semi-conﬂuent 
monolayers of the B16-F1 and B16-F10 cells were exposed to a single UVA dose 
at 8 J/cm2. The expression of N and E-cadherin was determined at 1, 4 or 24-h 
after irradiation using polyclonal goat anti-mouse antibodies. The melanoma cells 
were harvested with versene and incubated with the appropriate anti-cadherin 
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antibody solution for 1h. Thereafter, the cells were washed and incubated 
for 30 min on ice with ﬂuorescein-conjugated donkey anti-goat IgG second 
antibody. Following this, the cells were washed once with cold PBS and ﬁxed 
with formalin. The cadherin expression was analyzed by ﬂowcytometer.
3.4 In vivo experimental set up 
3.4.1 Animals
Female C57BL/6 (C57BL/6JOlaHSd) mice, with Speciﬁc Pathogen Free (SPF) 
status according to Felasa Health Monitoring Guidelines, were purchased from 
Harlan, The Netherlands, and housed in Viikki Laboratory Animal Center, 
University of Helsinki, Finland. The ethical evaluations of the experiments were 
reviewed and approved by the Institutional Animal Use and Care Committee 
of the University of Helsinki and the State Provincial Veterinarian Ofﬁce of 
Southern Finland. The care, welfare and use of the animals were in accordance 
with national, institutional and European guidelines. The mice were at 8–10 
weeks of age at the beginning of the experiments. The mice were housed and 
arranged for the experiments to groups of ﬁve. 
3.4.2 In vivo UVA irradiation of mice
Hair on the abdomens of the mice was shaven off to allow UVA irradiation of 
the skin. A suspension of 50,000 of B16-F1 or B16-F10 cells in 0.2 ml of saline 
was i.v. injected into the tail vein of anesthetized C57BL/6 mice (Figure 5). 
Figure 5. C57B/6 mice were injected with 50.000 non-exposed B16 melanoma cells i.v. 
into the tail vein, after which the mice were UVA exposed with single dose of 8J/cm2 
or 3x8J/cm2. Their lungs were collected and examined 14 days after the melanoma cell 
injection
UVA
d1 d2 d3… …d14
melanoma cell
injection
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Figure 6. B16-F1 cells were irradiated in vitro with an UVA dose of 8 J/cm2, after which 
50.000 UVA-exposed melanoma cells were i.v. injected into the tail vein of C57BL/6 mice. 
Their lungs were collected and examined 14 days after the melanoma cell injection.
d1
Injection …d14
UVA
B16-F1 cells
Immediately following the B16-F1 melanoma cell injection, the abdominal side 
of the mice was exposed to a single UVA dose at 8 J/cm2. Some of the animals 
were exposed to two more UVA doses (8 J/cm2) on two consecutive post-injection 
days. The non-exposed, anesthetized control mice groups were injected with 
B16-F1 or B16-F10 cell lines. The mice were terminated 14 days after the 
melanoma injection and their lungs were removed and ﬁxed in Bouin’s solution, 
after which the tumor colonization in their lungs was evaluated.
3.4.3 In vitro UVA irradiation of B16-F1 cells before i.v. injection
The B16-F1 melanoma cells were exposed to a single UVA dose of 8 J/cm2 and 
the irradiation was performed at room temperature in a dark room on a black 
support in order to avoid the effects of reﬂected radiation. The non-irradiated 
control B16-F1 and B16-F10 cells were sham-treated by keeping them at room 
temperature in a dark room for the irradiation time. After UVA exposure or 
sham treatment, a suspension of 50,000 of B16-F1 or B16-F10 cells in 0.2 
ml of saline was i.v. injected into the tail vein of anesthetized C57BL/6 mice 
(Figure 6). The mice were terminated 14 days after injection and their lungs 
were removed and ﬁxed in Bouin’s solution, after which the tumor colonization 
in their lungs was evaluated.
3.4.4 Evaluation of the metastases
The quantitative and qualitative evaluation of the lung metastases was 
performed under a dissecting microscope. The metastases visible on the lung 
surface were counted and scored according to their size, color, growth pattern 
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and uniformity. After quantitative and qualitative evaluation, the lungs 
were embedded in parafﬁn, cut into 5µ-sections and stained for histological 
analysis.
3.4.5 Immunohistochemistry 
After quantitative and qualitative evaluation, the lungs were embedded in 
parafﬁn, cut into 5µ-sections and stained with hematoxyline-eosine in a standard 
fashion in order to evaluate tissue morphology and to examine for the presence 
of invisible micrometastases in tissue parenchyma under a dissecting microscope 
(Figure 7.) To conﬁrm the melanoma origin of the metastases, Melan-A (Chen 
et al. 1996), a marker antigen of melanoma cells was detected using indirect 
immunohistochemistry as well as the expression levels of cadherin N and E 
in order to determine the cadherin proﬁle of the metastases (Figure 8.). Parafﬁn 
sections were immunoassayed with goat polyclonal primary antibodies against 
Melan-A, E-cadherin and N-cadherin using horseradish peroxidase-conjugated 
secondary and third antibodies and an AEC-chromogen staining kit.
Figure 7. The cross sections of lungs were stained with H&E to determine lung tissue 
morphology and the appearance of metastases. H&E staining revealed that the vast 
majority of metastases were located close to the lung surface and only very rarely in the 
lung parenchyma. The majority of metastases were ﬁlled with melanin droplets (seen in 
black). The cross sections were immunostained with antibody against Melan-A to conﬁrm 
that the tumor metastases were indeed of melanoma origin. 
H&E Melan A
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3.4.6 Contact hypersensitivity (CHS) assay
UVA-induced systemic immunosuppression was studied using contact 
hypersensitivity assay according to the same irradiation protocol and doses of 
UVA (8 J/cm2 and 3x8 J/cm2) as in the previous in vivo experiments. The mice 
that were irradiated on the shaved abdomen to one UVA dose of 8 J/cm2 belonged 
to groups A1 and C1, and the mice that were irradiated to three UVA doses of 
8 J/cm2 applied in consecutive days (3x8 J/cm2) belonged to groups A2 and C2. 
Groups C1 and C2 formed the irritant controls for groups A1 and A2. The ears 
of the UVA-exposed mice were covered with a “cap” made from black plastic and 
insulation tape in order to avoid UV-mediated alterations in CHS response when 
challenging ears 10 days later (Reeve 2002). The non-exposed, anesthetized, 
positive control groups for CHS formation were designated B1 and B2 and the 
irritant control groups for these mice were designed D1 and D2. Three days 
after the last UVA dose, 2% oxazolone was applied under light anesthesia as a 
sensitizer (100 µl, corresponding 2 mg of oxazolone) to the shaved back of groups 
A1, A2, B1 and B2. The challenging dose of the sensitizer (10 µl, corresponding 
20 µg of oxazolone) was applied under light anesthesia to both ear pinna 7 days 
after sensitization for all groups. The thickness of the ears was measured before 
application and 24h later by using the springmicrometer. The ﬁgure for ear 
swelling for individual mice was calculated from both ears by subtracting the 
original thickness from the challenged ear thickness and taking the average 
from these two values. The UVA induced suppression was calculated according 
to the formula below, where A, B, C, and D were the average swelling ﬁgures for 
the respective animal groups 24 hours after challenge (Laihia & Jansen 1994): 
1- [(A-C)/(B-D)] x 100% 
Figure 8. The cross sections of lungs were immunostained with antibodies against 
E-cadherin and N-cadherin. The cadherin expression proﬁle showed that the lung 
metastases were strongly N-cadherin positive whereas E-cadherin staining remained 
weaker. 
N-cadherin E-cadherin
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3.4.7 The relative transmittance of UVA through mice skin
Skin transmittance was measured using the Bentham DM 150 spectroradiometer 
(Bentham Instruments Ltd., England). A Philips HP 3136 sun lamp was used 
as a light source. Although the irradiance of the Philips HP 3136 sun lamp is 
higher when compared with the Philips HB 171/A face solaria used in the animal 
experiments, the relative transmission through mice skin remains the same.
The abdominal hair of the mice was shaven, the mice were sacriﬁced and 
their skin was removed. The abdominal location and the size of removed skin 
were identical to that used in the in vivo mice experiments. The transmittance 
was measured within 30 minutes after skin removal. The lamp spectrum was 
ﬁrst measured without the mouse skin, after which spectral measurements 
were performed on three mice skins. The relative transmittance was calculated 
by dividing the spectrum of mice skin by the spectrum without the skin (Figure 
9A). Finally, the spectral irradiance transmitted through the mouse skin during 
in vivo exposures was determined by multiplying (weighting) the spectrum of 
relative spectral transmission with the spectrum of Philips HB 171/A face solaria 
(Figure 9B). This spectrum depicts the true spectral transmittance during the 
animal experiments. 
Figure 9. A) The spectral measurements of three mice skins were performed within 30 
minutes after skin removal. The relative transmittance varied in the samples from 5–15% 
in the UVA region. The average transmittance from the three measurements is indicated 
by a thick line. B) The spectral transmittance of the in vivo study was determined from 
the average value of the relative transmittance. The spectral irradiance of the Philips face 
solaria is indicated with a thin line and the transmitted spectral irradiance is indicated 
with a thick line.
A. B.
1,0E-06
1,0E-05
1,0E-04
1,0E-03
1,0E-02
1,0E-01
1,0E+00
1,0E+01
1,0E+02
1,0E+03
1,0E+04
280 300 320 340 360 380 400
Wavelength [nm]
S
pe
ct
ra
l i
rr
ad
ia
nc
e
[m
W
/m
²n
m
]
UV-AUV-B
0,00
0,02
0,04
0,06
0,08
0,10
0,12
0,14
0,16
0,18
0,20
280 300 320 340 360 380 400
Wavelength [nm]
T
ra
ns
m
itt
an
ce
 %
65
STUK-A216
3.5 Gene expression analysis
3.5.1 Differentially expressed genes
Large-scale screening was performed using Atlas™ complementary (cDNA) 
mouse cancer 1.2 array (Clonetech Laboratories, Palo Alto, CA). The B16-F1 
melanoma cells were exposed to a single UVA dose of 8 J/cm2 and the irradiation 
was performed at room temperature in a dark room on a black support in order 
to avoid the effects of reﬂected radiation. The non-irradiated control B16-F1 
cells were sham-treated by keeping them at room temperature in a dark room 
for the irradiation time. 
RNA was isolated 4 hours after the end of UVA exposure. The cells 
were collected by brief trypsinization and washed twice with ice cold PBS. 
The total RNA was isolated from melanoma cells using Nucleospin® RNA II 
kits (Clonetech Laboratories, Palo Alto, CA) and the RNA concentrations were 
determined spectrophotometrically. The poly A+ RNA enrichment of 50-µg total 
RNA and 32P-labeled cDNA probe synthesis made by reverse transcription were 
performed according to the Atlas™ Pure Total RNA Labeling System (Clonetech 
Laboratories, Palo Alto, CA). Precisely the same amounts of 32P-labeled cDNA 
from control and UVA exposed melanoma cells were used as a probe in Atlas™ 
Mouse Cancer 1.2 cDNA expression arrays containing 1176 tumor related genes 
immobilized on a nylon membrane. Hybridization and washing procedures were 
performed according to the recommendations of the manufacturer. The x-ray ﬁlm 
was exposed at -70ºC simultaneously to the membrane hybridized with a control 
probe and to the membrane hybridized with a UVA exposed probe. 
The hybridization signals on the autoradiograms were scanned using a 
GS-710 Calibrating Imaging Densitometer and the intensity of the gene spots 
was analyzed with AtlasImage 2.0 Software. The analysis of the membranes 
was performed according to the manufacturer’s instructions. The ratio of two 
corresponding gene spots between control and UVA exposed spots was calculated 
by dividing the intensity of the UVA exposed gene by the intensity of the non-
exposed control gene. To select the genes with altered expression level, the 
signiﬁcance of upregulation was set at ratio ≥ 1.7 and downregulation at ratio ≤ 
0.6. Subsequently, the existence of the spots on the ﬁlm was veriﬁed visually. The 
student t-test was performed on selected genes in order to calculate statistical 
signiﬁcance.
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3.5.2 Western blot analysis
The B16-F1 melanoma cells were exposed to the single UVA dose of 8 J/cm2 at 
room temperature. The non-irradiated control B16-F1 cells were sham-treated 
by keeping them at room temperature for the irradiation time. The B16-F1 
melanoma cells were harvested by versene immediately after the end of UVA 
exposure and thereafter at 1-6, 8 and 10 h time-points. The melanoma cells were 
washed with PBS and lysed with 2.5% sodium dodecylsulfate supplemented 
with 1% proteinase inhibitor cocktail. The protein concentration was measured 
according to Lowry (Lowry et al. 1951). Samples containing 20 µg protein per 
lane were resolved using 7.5% SDS-PAGE gel and blotted on PVDF membranes. 
The membranes were blocked in room temperature for one hour in a 2% blocking 
solution, followed by overnight incubation ﬁrst in an anti-cyclin G antibody 
solution at +4ºC. Thereafter, the membranes were washed and incubated for 1 
h in a secondary antibody solution of horseradishperoxidase-conjucated anti-
mouse immunoglobulin G at room temperature. The membranes were washed 
with PBS and the chemiluminiscence signal was detected by exposing an x-ray 
ﬁlm to the membrane. Autoradiograms were scanned by GS-710 Calibrating 
Imaging Densitometer (Bio-Rad Laboratories, Hercules, CA) and the intensity 
of protein bands was analyzed by Phoretix analysis software (1D v2003.01) from 
three different experiments. The student t-test was performed to calculate the 
statistical signiﬁcance of the change.
3.5.3 Cell cycle analysis
The cell cycle was studied by examining the DNA content of the B16-F1 cells 
by using the propidium iodide staining method (Leszczynski et al. 1995). The 
B16-F1 melanoma cells were exposed to the single UVA dose of 8 J/cm2 at room 
temperature. The non-irradiated control B16-F1 cells were sham-treated by 
keeping them at room temperature for the irradiation time. B16-F1 melanoma 
cells were collected either immediately after the end of UVA exposure, or at the 
same time-points thereafter than Western blot samples, by brief trypsinization. 
Cells were washed twice with cold PBS, and ﬁxed in methanol. After ﬁxation, the 
melanoma cells were washed twice with cold PBS followed by incubation in an 
RNAse solution in PBS (100 units/ml) for 30 minutes at 37ºC. The melanoma cells 
were incubated in propidium iodide solution in PBS (10 µg/ml) overnight at +4ºC. 
The ﬂuorescence was measured using FACScan ﬂow cytometry (Becton Dickinson, 
USA) and analyzed with the ModFitLT V3.1 (PMac) cell cycle analysis application 
(Becton Dickinson, USA). The student t-test was performed to calculate the 
statistical signiﬁcance of the change.
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4. Results 
The main results of this study are presented and discussed in Publications I–IV. 
Here, a summary of the results is presented. The numbers (I–IV) located in the 
titles refers to the publication where detailed descriptions are found. Additional 
data from the transmittance of mice skin is included. 
4.1 UVA effects on melanoma adhesiveness in vitro (II)
To determine whether UVA affects tumor cell adhesiveness to endothelium, the 
binding assays were executed between non-irradiated endothelial monolayer and 
UVA exposed melanoma cells. The single doses of UVA at 2 J/cm2 and 4 J/cm2 
caused small, statistically non-signiﬁcant, changes in cell adhesion at tested time-
points in both cell lines. A UVA dose of 8 J/cm2 affected adhesiveness 24 hours 
after irradiation. At that time, the adhesiveness of the B16-F1 cells increased 
by 88% (P << 0.001) whereas the adhesiveness of the B16-F10 cells increased 
only by 28% (P< 0.05) The highest used dose of UVA (12 J/cm2) caused 25% (P< 
0.05) increase in B16-F1 adhesiveness already 4 hours after exposure. At this 
time point, there were no detectable changes in the adhesiveness of the B16-
F10 cells. Later, 24 hours after the irradiation, the adhesiveness of both cell 
lines increased by 32% (B16-F1, P< 0.005) and 55% (B16-F10, P<< 0.001). The 
highest used UVA dose (12 J/cm2) appeared to be less effective than the lower 
dose (8 J/cm2). 
To study whether UVA exposure induces melanoma cell apoptosis, which 
could affect the adhesiveness of melanoma cells and thus altering the outcome 
of the adhesion assay, the morphology of the B16-F1 and B16-F10 melanoma 
cells exposed to UVA was examined. Cell viability and apoptosis were examined 
at 1, 4 and 24 h after UVA exposure at doses of 2, 4, 8 and 12 J/cm2. Neither cell 
viability nor apoptosis were affected by UVA doses up to 8 J/cm2. However, the 
highest used dose (12 J/cm2) caused up to 20.1% of cell death among the highly 
metastatic B16-F10, but not among the low-metastatic B16-F1 cells. 
UVA dose of 8 J/cm2 split into four fractions of 2 J/cm2 with three one-hour 
intervals between  exposures increased the adhesiveness of the low-metastatic 
B16-F1 cells by 149% (P<< 0.001) already one hour after the end of the last of 
2 J/cm2 exposures. Thereafter, the adhesiveness of the B16-F1 declined and 24 
hours after the exposure the increase in adhesiveness was only 64.1% (P< 0.01). 
In the highly metastatic B16-F10 cell line, repetitive exposure protocol increased 
adhesiveness by 132% (P << 0.001), but the effect was observed only 24 hours 
after the end of the last exposure. The UVA effect on melanoma-melanoma 
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adhesion (aggregation) was examined using a UVA dose of 8 J/cm2, which 
was found to be the most efﬁcient by inducting the melanoma adhesion to 
endothelium. The UVA caused almost 60% (P< 0.05) decline in B16-F1 and B16-
F10 aggregation, which was observed 1 hour after exposure. This effect was no 
longer statistically relevant at the 4-h time-point, although the tendency to 
declined aggregation remained. Exposing of cells to 8 J/cm2, but delivered as 
4 doses of 2 J/cm2 that were separated by 1-h intervals, had a weaker effect and 
caused decline in the B16-F1 and B16-F10 aggregation only by ca. 35% (P< 0.05 
and P= n.s., respectively). The tendency of decline in cell aggregation caused by 
the fractionated-dose-exposure was also observed 4 hours after exposure, but 
the results were not statistically relevant. 
To examine the effect of UVA exposure on the expression of cadherins, two 
separate pilot experiments were performed to determine the expression of N and 
E-cadherin on the surface. The expression level of N-cadherin was increased by 
UVA in the B16-F1 cells at 1-h and 4-h time-points in both experiments. The 
E-cadherin expression was downregulated in the B16-F1 cells at the 1-h time-
point in both experiments. In the highly metastatic B16-F10 cells, the UVA caused 
no signiﬁcant changes in E-cadherin expression, but the N-cadherin expression 
slightly increased 24 hours after UVA exposure. 
Table 9. Metastases formation in mice lungs after in vivo irradiation of mice
F1 / F10 = i.v. 50,000 cells/animal; UVA = 8J/cm2
UVA only or NaCl only did not induce spontaneous metastases
Mice Tumors Score
F1 10 27 259
F10 10 70 511
F1 + UVA 10 117 978
F1 + 
3xUVA
10 72 519
Mice Tumors Score
F1 10 2 15
F10 10 25 274
F1 + UVA 10 27 258
F1 + 
3xUVA
10 27 170
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4.2  UVA effects on the metastatic potential melanoma in vivo 
(I, III)
The UVA effects on melanoma metastasis were studied using C57BL/6 mice 
and syngenic C57BL/6-derived B16-F1 and B16-F10 melanoma cell lines. The 
outcome of the two animal experiments is summarized in Table 9. The control 
mice injected with saline or exposed to UVA, but not injected with melanoma 
cells, developed no spontaneous metastases, as expected. The injection of low-
metastatic potential B16-F1 without UVA-irradiation led to the development of 
a smaller number of metastases when compared to the positive control animals, 
which were injected with high-metastatic B16-F10 cells. Animals injected with 
low-metastatic B16-F1 cells and irradiated with a single dose of UVA (8 J/cm2) 
developed 12-fold and 4.3-fold more pulmonary metastases in comparison with 
the non-exposed control mice (Table 9). The exposure of mice injected with B16-F1 
to three consecutive doses of UVA (8 J/cm2 each) caused no additional increase 
in melanoma metastasis. Interestingly, the score obtained for the metastases 
from animals exposed to three doses of UVA was lower than the score obtained 
for the animals exposed to a single dose of UVA. 
Histological evaluation of haematoxylin-eosin stained tissue sections as 
well as immunohistochemical analysis of the expression of the Melan-A/MART-1 
antigen conﬁrmed that the metastatic nodules appearing in the lungs were of 
melanoma origin (Figure 7). The expression level of cadherin E and N-cadherin 
was determined to show that lung metastases were strongly N-cadherin positive, 
whereas E-cadherin staining remained weaker (Figure 8). 
The transmittance of the UVA wavelengths in mice skin was measured 
in order to determine whether UVA reaches the dermis and thus, presumably 
the circulating melanoma cells in the capillary network. According to the 
measurements, the transmission varied from 5% to 15% in the UVA wavelengths 
used in this study (Figure 9). 
To study the direct effect of UVA on the pulmonary colonization capacity 
of melanoma, B16-F1 cells were exposed in vitro, whereas the control cells were 
sham-treated. Animals injected with control B16-F1 cells again developed fewer 
metastases when compared to the animals injected with the positive control 
B16-F10 cells (Table 10). The in vitro UVA exposure applied directly on B16-F1 
melanoma prior to the injection into mice increased the metastatic capacity of 
melanoma cells 1.5-fold. 
In the positive control group for CHS induction, the mean ear swelling 
responses were 31.2 x 10-2 mm (Table 11). When the C57BL/6 mice were 
irradiated with 8 J/cm2 on the abdomen, the mean ear swelling responses were 
26.9 x 10-2 mm, representing a 13.8% decline in ear swelling when compared to 
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the non-UVA-exposed group (Table 11). Irradiation of mice with three consecutive 
UVA doses did not induce decline in CHS induction as shown in Table 11. 
4.3 Transcriptional analysis of UVA affected genes (IV)
Gene expression analysis was performed in order to examine UVA-induced 
changes on the transcriptional level in B16-F1 mouse melanoma 4 hours after 
UVA irradiation. The cDNA study revealed that a physiologically relevant UVA 
dose induced nine differentially expressed genes in the melanoma cells exposed 
to UVA when compared to the unexposed control cells (Table 12). Seven genes 
Table 10. Metastases formation in mice lungs after in vitro irradiation of B16-F1 
melanoma cells.
Mice Tumors Score
F1 10 22 157
F10 10 82 515
F1 + UVA 10 34 202
F1 +
3xUVA
- - -
Table 11. Suppression of oxazolone induced CHS in C57BL/6 mice (10 mice per 
group).
Group UVA
8 J/cm2
Sens Ear swelling ± SD
10-2 mm
A + + 39.1 ± 4.4
B - + 42.9 ± 5.3
C + - 12.2 ± 3.3
D - - 11.7 ± 4.0
Group UVA
3x8J/cm2
Sens Ear swelling ± SD
10-2 mm
A + + 38.1 ± 5.6
B - + 40.2 ± 6.0
C + - 9.7 ± 3.5
D - - 11.9 ± 2.9
Mean ear swelling  (A-C)  39.1 - 12.2 = 26.9
Mean ear swelling  (B-D)  42.9 - 11.7 = 31.2
Mean ear swelling (A-C)     38.1- 9.7 = 28.4
Mean ear swelling (B-D)     40.2-11.9 = 28.3
A: UVA-irradiated abdomen, sensitized back and challenged ear 
B: Sensitized back, challenged ear 
C,D: Irritant controls
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out of nine were upregulated, involving stress response (HSC70, HSP90a/HSP86, 
a-B-crystallin), oxidative stress (GST mu2, Oxidative stress induced protein), 
angiogenesis (VEGF), and cell cycle regulation (cyclin G). However, two genes 
out of nine were downregulated, involving cell motility (G-actin, non-muscle 
coﬁlin). 
Cyclin G was examined further, since it was the most UVA-affected gene. 
The protein expression of cyclin G in B16-F1 melanoma cells was examined 
immediately after the end of exposure and at different time-points thereafter. 
In spite of the statistically signiﬁcant almost 5-fold upregulation in the gene 
expression, the cyclin G protein expression was only moderately affected by 
Table 12. Differentially expressed genes after UVA dose of 8 J/cm2
Gene  family No. of 
arraysa
Controlb
± SD 
UVA exposedc
± SD 
t-test Ratiod
Stress induced  
Heat shock 86-kDa 
protein (HSP86; HSP90�)
3 � 0,32 ± 0,23 1,04 ± 0,44 0,43 3,23
Heat shock cognate 
71-kDa (HSC70; HSP73) 
2 �
1 �
0,15 ± 0,12 0,27 ± 0,18 0,39 1,81
Alpha crystallin
B-subunit      
3 � 0,07 ± 0,03 0,21± 0,07 0,05 3,26
Oxidative Stress 
Oxidative stress-
induced protein  
2 �
1 �
0,16 ± 0,14 0,31± 0,15 0,27 1,92
glutathione
S-transferase mu2
3 �
1 �
0,07 ± 0,04 0,14 ± 0,09 0,23 2,09
Cell cycle control 
cyclin G 5 � 0,13 ± 0,04 0,65 ± 0,36 0,03 4,85
Angiogenesis
Vascular endothelial 
growth factor (VEGF) 
4 � 0,07 ± 0,03 0,22 ± 0,08 0,03 2,94
Skeleton & Motility 
proteins
G-actin cytoplasmic 3 � 1,02 ± 0,37 0,47 ± 0,18 0,10 0,47
non-muscle cofilin 1 3 � 0,40 ± 0,10 0,17 ± 0,01 0,05 0,41
a The number of arrays (out of five) in which differences in the gene expression were observed.;  
The arrows indicate the upregulation or downregulation of the gene. In the remaining arrays no  
difference was observed. 
b The average of the normalized gene intensity in control cells ± standard deviation; 
c The average of the normalized gene intensity in UVA exposed cells ± standard deviation. 
d Ratio of UVA exposed genes versus control genes.     
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UVA. There was a 1.36-fold increase in the cyclin G expression at 6h time point; 
however, this was statistically non-signiﬁcant.
The cyclin G functions in the nucleus as the cell cycle regulator. Thus, the 
effect of UVA the cell cycle arrest in G2/M restriction point in B16-F1 cell line 
was determined at the time-points where the protein analysis was performed. 
The UVA exposure induced cell cycle arrest, beginning at the 4-h time-point. 
The observed G2/M arrest has increased in a time- dependent manner, peaking 
at 8-h time-point (p<0.05), after which it somewhat declined.
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5. Discussion
5.1 The UVA effect in melanoma adhesiveness in vitro
This study demonstrated that UVA induced alterations in the adhesiveness of 
mouse melanoma cell lines B16-F1 and B16-F10 and the syngeneic endothelial 
MS1 cell line. This in vitro study shows for the ﬁrst time that melanoma cells 
became less “sticky” among themselves but become more adhesive to the 
endothelial monolayer after UVA irradiation. A single dose of UVA was shown 
to induce an increase in melanoma-endothelium adhesion and a decline in 
melanoma-melanoma adhesion. Small, repetitive doses of UVA had a stronger 
effect on melanoma-endothelium adhesion than a single-bolus dose does. This 
suggests that at least in vitro repetitive exposure to small UVA doses might 
be more efﬁcient in inducing cell adhesiveness when compared with a single-
bolus dose of the same total amount. The multiple dose irradiation protocol had 
a weaker effect on melanoma-melanoma aggregation, especially at latter time-
points. 
Interestingly, our UVA-derived in vitro results appear to have a direct 
effect because the changes in the adhesiveness and in the adhesion molecule 
expression occurred in the absence of any keratinocyte-derived soluble factors. 
This in vitro data suggests that UVA exposure might help melanoma to form 
metastases by easing the detachment of melanoma cells from the primary 
tumor (a weakening of melanoma-melanoma adhesion) and by enhancing their 
extravasation in target organs (an increase in melanoma-endothelial adhesion). 
Therefore, these results have conﬁrmed the original hypothesis and they agree 
with the in vivo data obtained. 
Then in vitro evidence presented in this study is in agreement with previous 
studies that have shown enhanced cell adhesion after UVA irradiation. UVA has 
been shown to alter the adhesive properties of cells by increasing the adhesion 
of endothelial cells to peripheral blood derived granulocytes, lymphocytes and 
monocytes (Heckmann et al. 1997). UVA is known to stimulate ﬁbroblast adhesion 
to collagen (Tupet et al. 1999) and melanocyte adhesion to ﬁbronectin (Neitmann 
et al. 1999) through the expression of integrins. The cumulative effect of UVA 
radiation on melanoma-endothelial adhesiveness presented in this study is also 
consistent with studies where the cumulative effect of repetitive exposure to 
UVA and UVB radiation were observed on skin (Parrish et al. 1981; Lavker et 
al. 1995a; Chouinard et al. 2001; An et al. 2001).
The adhesiveness at the highest UVA dose in this study might be affected 
by cell death, since agents inducing cell apoptosis might also induce these cells 
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to be more adhesive to healthy cells, thus altering the outcome of the adhesion 
assay. Apoptotic cells begin to express phospahatidyl-serine residues, which 
mediate the attachment and the phagocytosis of dying cells to the neighboring 
cells. Apoptotic death was not observed in either B16 cell line in any time-point. 
Only the highest used dose (12 J/cm2) caused up to 20.1% of cell death among the 
highly metastatic B16-F10, but not among the low-metastatic B16-F1, cells. This 
suggests that although the adhesiveness data obtained with the highest UVA dose 
(12 J/cm2) might be compromised by the cell apoptosis-associated adhesiveness, 
the adhesiveness data obtained at lower doses (2-8 J/cm2) are not. 
The initial step of melanoma metastasis is the detachment of cells from 
the primary tumor and invasion to the surrounding tissue. The strength of 
melanoma-melanoma interaction in the primary tumor mass is mainly regulated 
by E-cadherin, and its downregulation has been shown to play an important role 
in loosening the primary tumor (Hsu et al. 1996; Johnson 1999; Li & Herlyn 
2000). The experiments performed in this study suggest that UVA exposure might 
upregulate the expression of N-cadherin and simultaneously downregulate the 
E-cadherin expression. This change might be an indicator of the acquisition of 
pro-metastatic phenotype by the UVA exposed melanoma cells. Furthermore, 
our pilot observations concerning the UVA-induced decline in the E-cadherin 
expression one hour after the exposure support the observed decline in the 
aggregation of melanoma cells that also occurred at the 1-h time-point. Such 
effect, if also occurring in vivo, could enhance the detachment of single cells from 
the solid tumor mass and their subsequent invasion to the host stroma and thus, 
enhance the metastatic potential of melanoma. 
UVA radiation might also alter the adhesive properties of tumor cells by 
affecting the expression of cell surface adhesion molecules via increased PKC 
expression (Leszczynski et al. 1995; Leszczynski et al. 1996). Moreover, PKC 
activation and translocation to the plasma membrane has been shown to be 
involved in melanoma metastasis (Gopalakrishna & Barsky 1988; Rusciano 2000). 
The high level of PKC expression together with a low E-cadherin expression has 
been shown to contribute to the high migratory activity of colon carcinoma cells 
(Masur et al. 2001) as well as to low homotypic cell aggregation potential (Batlle 
et al. 1998). Thus, one can assume that also UVA-mediated downregulation of E-
cadherin might act in concert in UVA-induced PKC activation and thus decrease 
the homotypic-binding between tumor cells and simultaneously enhance their 
metastatic potential. Whether this hypothesis also holds true in B16-F1 and B16-
F10 cell lines should be determined in further studies that investigate molecular 
mechanisms and intracellular signal transduction pathways. 
75
STUK-A216
5.2 UVA effect on melanoma metastasis in the mouse model
The in vivo studies have shown a novel ﬁnding; the irradiation of mice with 
single dose of UVA that have low-metastatic melanoma cells in their blood 
circulation increases the formation of pulmonary melanoma metastases. In both 
animal studies, the metastases formation of B16-F1 cells after UVA exposure 
was comparable with the level of metastases formation by the highly metastatic 
B16-F10 cell line. These results suggest that UVA exposure has caused an 
induction of high-metastatic potential in the normally low-metastatic potential 
melanoma cells. 
The UVA dose of 8 J/cm2, which was used throughout the in vivo study, was 
selected based on the result of the in vitro adhesion assay between irradiated 
melanoma cells and non-irradiated endothelium: the dose of 8 J/cm2 was 
demonstrated to be the most effective in affecting cell adhesiveness without 
causing cell death. Moreover, it roughly corresponds to the UVA dose received 
approximately within 1 hour on a sunny summer day in Finland, thus being 
physiologically relevant. 
Since the consecutive UVA exposures increased dramatically the adhesion 
of UVA-exposed low-metastatic B16-F1 cells to endothelium in the in vitro 
adhesion assay, the multiple dose effect was also tested in the in vivo mouse 
model by exposing the mice to the additional UVA doses of 8 J/cm2 at 24 and 48 
hours after the melanoma cell injection. The repetitive exposure pattern mimics 
human behavior when tanning in a solarium. The exposure of the animals on a 
three consecutive days had an unexpected effect in that the number of metastases 
in their lungs did not increase when compared to the animals that received a 
single dose. This postulates the possibility that consecutive exposures might 
cause some kind of suppressive effect on the generation of metastases. 
The two animal studies had a different baseline for the formation of 
metastases. All the treatments, the animal handling procedures and melanoma 
cells lines were kept the same in both studies. Thus, the differences might be 
caused by differences between the animal batches or by the changes in B16 cell 
lines. Nevertheless, the phenomenon remained the same in both experiments, 
showing the capability of UVA to enhance the metastatic potential of the low-
metastatic mouse melanoma B16-F1 cell line. Moreover, the injection of low-
metastatic potential B16-F1 without UVA irradiation led to the development of 
a smaller number of metastases when compared to the positive control animals 
injected with high-metastatic potential B16-F10 cells in both experimental 
set-ups. These results are in agreement with the previously established low and 
high metastatic potential for B16-F1 and B16-F10 melanoma cell lines (Fidler 
1973; Fidler 1975), thus conﬁrming the validity of the experimental set-ups.
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Cell adhesion molecules play an important role in the regulation of 
metastatic cascade. Changes in the expression of adhesion molecules are 
shown to facilitate the metastatic spread of tumor cells (Hart et al 1991).The 
immunohistological analysis of the cadherin expression proﬁle of melanoma 
metastases in lungs revealed a strong N-cadherin positive staining pattern and 
weak E-cadherin expression. This result is in agreement with our in vitro result 
that showed a shift in the cadherin expression proﬁle from E to N-cadherin. The 
loss of E-cadherin expression has been found to correlate with the progression and 
invasive phonotype of carcinoma cells in vivo (Perl et al. 1998). This may result 
in disturbed cell-cell interactions and enhance tumor formation and invasion 
(Hsu et al. 1996; Meier et al. 1998; Li & Herlyn 2000). 
Some 20–50% of UVA radiation delivered to the skin penetrate into the 
dermis in Caucasian skin, and dermal microvascular endothelial cells have been 
shown to be a direct target of the UVA (Heckmann et al. 1997). The thickness of 
mouse epidermis is approximately 10 µm and for dermis 250 µm (Hansen et al. 
1984), thus being signiﬁcantly thinner when compared to human skin (1–4 mm). 
UVA most likely also reaches the dermal compartment in mice skin. According 
to our measurements, approximately 90% of the UVA wavelengths used in this 
study were absorbed in the skin and ~10% was transmitted through it. Thus, 
in our set-up the UVA radiation was likely to penetrate into the dermis layer of 
mouse skin and had the potential to irradiate the melanoma cells in the blood 
circulation. 
It is not, however, possible to say whether UVA truly reaches the metastazing 
melanoma cells in mice skin capillaries. In order to study how much of the 8 J/
cm2 dose directly affects the metastatic potential of B16-F1 melanoma cells, the 
low-metastatic potential B16-F1 cells were in vitro irradiated with a single dose 
of UVA prior to injection. This treatment increased the metastatic capacity of 
the melanoma cells only 1.5-fold, which means that mechanism(s) other than the 
direct UVA-induced adhesiveness of melanoma cells may play a role in the UVA-
induced increase of metastasis. UVA may have caused the generation of soluble 
factors by the skin cells, which might enhance the pro-metastatic effect of UVA. 
UVA has been shown to cause a release of some keratinocyte and ﬁbroblast-
derived soluble factors, e.g. cytokines (Corsini et al. 1997; Kondo & Jimbow 1998; 
Kondo 1999), eicosanoids (Hanson & DeLeo 1989) and proteolytic enzymes, such 
as MMPs (Wlaschek et al. 1994; Petersen et al. 1995). 
UVA-induced immunosuppression occurred either locally (Bestak & 
Halliday 1996; Halliday et al. 1998; Damian et al. 1999) or systemically (Byrne 
et al. 2002) and might also be responsible for increased melanoma metastasis 
by impairing the rejection of invasive tumor cells in the UV-exposed host. 
This study measured systemic immunosuppression by performing the widely 
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used CHS assay. It showed that a single UVA dose at 8 J/cm2 caused a 13.8% 
increase in systemic immunosuppression when compared to the non-exposed 
control animals. Byrne et al. have also showed that UVA irradiation suppressed 
the systemic CHS reaction by using the same C57BL/6 mice strain as we had 
used (Byrne et al. 2002). UVA-induced immunosuppression of systemic CHS, 
however, was abrogated when three consecutive UVA doses were applied. This 
suggests the possibility that the consecutive exposures, i.e. the cumulative UVA 
dose, might diminish the immunosuppressive effect caused by a single UVA 
dose. A high dose of UVA has been shown to protect mice from UVB-induced 
immunosuppression, possibly via UVA-induced antioxidant activity (Reeve & 
Tyrrell 1999; Reeve & Domanski 2002; Allanson & Reeve 2004; Allanson & Reeve 
2005).  Moreover, in contrast to the primary UVA-induced immunosuppression of 
C57BL/6 mice, the further UVA irradiation of mice enhanced secondary immune 
responses (Byrne et al. 2002). Halliday has suggested that low doses of UVA 
may initiate the ROS production that mediates immunosuppression, whereas 
higher UVA doses stimulate the production of protective antioxidant enzymes 
such as HO-1, which reverses UVB-induced immunosuppression through the 
antioxidant effect (Halliday 2005). The results presented in this study agree 
with previously published studies and suggest that a single UVA dose could be 
immunosuppressive, but further doses can abolish this immunosuppressive effect. 
This result can also explain the observation that the UVA exposures delivered 
at the three consecutive days has weaker pro-metastatic effect than the single 
dose does.
As earlier results gathered mostly from animal studies have shown, 
UVA may have a role in the development of melanoma. The additional data 
from epidemiological studies suggest that the use of a sunscreen and artiﬁcial 
tanning may increase the risk of the onset of malignant melanoma due to, at least 
partially, the UVA burden gained during tanning sessions (Wang et al. 2001). The 
results presented in this thesis offer new evidence that UVA exposure increases 
the metastatic potential of the melanoma cells present in the blood circulation 
in a mouse model. The enhancement in the metastatic potential of melanoma 
is possibly caused in part by UVA-induced systemic immunosuppression and 
by the increased adhesiveness of UVA-irradiated melanoma cells. These results 
suggest that if occurring also in humans, exposure to UVA radiation, either solar 
or solaria-derived, might have the potential to cause an increase of melanoma 
metastasis in people who might be unaware of having early, yet undiagnosed, 
melanoma lesions. Whether similar UVA-induced pro-metastatic effects occur 
in people sunbathing or using solaria remains to be determined. In addition, 
it remains to be determined whether other tumors respond to UVA exposure 
in a similar manner. Considering the recent ﬁndings of UVA-induced DNA 
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mutations (Agar et al. 2004), this study further supplements and supports the 
notion that exposure to UVA radiation might be a more potential health hazard 
than previously suggested.
5.3 UVA effect on gene expression in melanoma cells
The cDNA study revealed that a physiologically relevant UVA dose might have 
more health implications than had previously been expected. From the analysis 
of 1176 cancer related genes, there were only 4 genes (cyclin G, VEGF, a-crystallin 
and non-muscle coﬁlin) with statistically relevant changes (p≤0.05) after UVA 
treatment. This suggests that the observed genes might be candidates involved 
in UVA-induced cellular stress. The small overall inﬂuence of UVA on the 1176 
cancer genes that were studied also suggests that melanoma cells, which are 
already transformed and have malignant phenotype, might be resistant to the 
UVA. The four-hour time-point was selected in order to give melanoma cells 
enough time to respond to UVA radiation; however, not too much time was given 
in order to avoid the indirect effects that take place over a longer period. The 4-h 
time-point was also used in the in vitro set-up, where alterations in the adhesive 
properties of the melanoma cells were observed 4 h after irradiation. The main 
problem with this experimental set-up was the uneven expression proﬁle of 
differentially expressed genes as in many genes, both up and downregulation was 
detected in the different repeats. In addition, poor reproducibility was seen in the 
lack of a detectable spot in every repeat (there were a total of  5 repeats).
With respect to the statistically relevant altered genes, the changes in the 
gene expression of cyclin G and VEGF genes might be related to the metastatic 
process. Cyclin G is one of the cell cycle regulators, localized in the nucleus and 
it is a transcriptional target for the p53 tumor suppressor protein (Okamoto 
& Beach 1994), thus contributing to G2/M arrest in response to DNA damage 
(Shimizu et al. 1998; Jensen et al. 1998). In our study, the expression of the 
cyclin G gene was signiﬁcantly upregulated with a 4.85-fold increase after UVA 
exposure in all ﬁve repeats. 
Angiogenesis is believed to be an early event in tumorigenesis and may 
facilitate tumor progression and metastasis. This study clearly demonstrated 
the upregulation in VEGF gene expression from UVA. The increase in the gene 
expression level was 2.9-fold, and it was repeated in 4 out of 5 experiments. 
UVA has been shown to mediate the induction of VEGF in the primary human 
keratinocytes (Mildner et al. 1999) and epidermal ﬁbroblasts (Trompezinski et 
al. 2000). Our ﬁndings agree with these results and show that UVA had an effect 
on VEGF expression in melanoma cells.
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The data obtained from a cDNA array is usually validated by some other 
method, such as the reverse transcriptase-polymerase chain reaction (RT-PCR). 
However, the most important issue concerning cell physiology is whether the 
upregulated mRNA is translated to the protein. Since the cyclin G gene was 
mostly affected by UVA, the protein expression was studied further. Western blot 
analysis revealed that the expression of cyclin G was affected by UVA radiation 
only moderately, as compared to the gene expression change. Therefore, the 
effect of UVA on cell cycle arrest, which is regulated by cyclin G analysis, was 
determined. Cell cycle analysis showed that UVA causes cell cycle arrest in 
G2/M check point beginning at the 4-h time-point and peaking 8 hours after the 
end of irradiation. Interestingly, at the same 4-h time point the 4.85-fold mRNA 
expression of cyclin G occurs. This observation postulates the notion that UVA-
induced cyclin G may induce, among other G2 checkpoint regulators, such as 
the cyclin B-cdk2-complex and p16 protein (Gabrielli et al. 1999;Pavey et al. 
1999), cell cycle arrest. In addition to cell cycle arrest, the p53-regulated cyclin 
G gene has been shown to promote cell growth in human colon carcinoma cells 
and ﬁbroblasts (Smith et al. 1997) instead of arresting the cell cycle. Therefore, 
future studies should be devoted to determining the effect of UVA-induced cyclin 
G upregulation on the proliferation of melanoma cells.
Our results suggest that UVA radiation-induced changes in the expression 
of several genes. Some of these changes, as shown an example of cyclin G, might 
affect cell physiology. The signiﬁcance of these gene expression results should 
be further conﬁrmed by examining the protein expression levels both in vitro in 
cell lines and in vivo in UVA exposed animals. The experimental approach using 
cDNA arrays could be further utilized to discover the genes responding to UVA 
in physiological studies aimed at detecting the health risks associated with UVA 
exposure. Moreover, the UVA effects on melanoma metastasis in humans cannot 
be studied using the same experimental procedures used in this study with mice. 
Therefore, large-scale screening methods, such as DNA arrays, provide a powerful 
tool to determine the new metastasis markers for humans.
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6. Conclusions 
An understanding of the physiological consequences of UVR exposure is of crucial 
importance in the prevention of melanoma. Despite highly developed diagnostic 
methods and effective clinical treatment and therapy, the metastatic potential of 
melanoma remains the main reason for mortality fro melanoma. To understand 
the melanoma metastasis process itself, we need to clarify which parameters, such 
as environmental factors, might be involved in the transformation of a primary 
melanoma phenotype into a metastatic phenotype. 
The effect of UVA on melanoma tumor metastasis has not been studied. 
This study presents the ﬁrst evidence suggesting that UVA exposure might be a 
physiologically relevant factor in regulating melanoma metastasis. The evidence 
supports the hypothesis that UVA increases the metastatic potential in mouse 
melanoma. This increase is likely due to the direct effect on the melanoma cell 
expression of adhesion molecules and to an indirect effect by causing systemic 
immunosuppression. Some other systemic effect(s), still unidentiﬁed, might also 
be involved. 
The observations derived from the mouse model could be extended to 
humans. For a large number of patients, melanoma metastasis has taken already 
place by the time of their diagnosis. Thus, there is the possibility that people 
who are unaware of already having a primary melanoma tumor and even 
hematogenously metastasizing melanoma might expose themselves to UVR. 
Our observations can be further extended into a hypothesis that suggests UVA 
exposure might enhance the metastatic potential and extravasation of other, non-
melanoma cancer cells, which might be present in the blood circulation of people 
exposed to UVA. If UVA-derived immunosuppression is the key factor involved 
in increasing the metastatic potential of melanoma, it most likely affects other 
cancer cells in a similar manner. Future research should determine whether 
solar or solaria-derived radiation, containing the residual UVB component, has 
the same effect on melanoma metastasis because UVB/SSR is known to be more 
immunosuppressive than UVA alone. Furthermore, what was not included in 
this thesis study, it would be of great importance to determine whether UVA 
or SSR induces the generation and/or secretion of well-known pro-metastatic 
chemokines, such as IL-8, from skin cells and from the melanoma tumor itself. 
Such studies would offer new insights into the possible role of environmental 
UV exposure on the spread of cancer metastasis.
Despite the scientiﬁc evidence indicating the health risks resulting from 
exposure to UVR and UVA, the majority of people still actively seek a tan. There 
appears to be a lack of understanding about a UVR-induced tan being neither 
81
STUK-A216
healthy nor protective and that it is a visible warning sign of UVR-induced 
cellular damage. The possibility of the pro-metastatic effects of exposure to UVA 
might not be of very high relevance for daily exposure. However, the effects of 
UVA might gain physiological relevance after periods of extensive sunbathing 
or tanning in a solarium. In the light of the results presented in this thesis, 
avoidance of solaria use could be well justiﬁed. 
While effective UVB sunscreens are available, they are not as efﬁcient in 
the UVA range. The lack of the adequate UVA ﬁlters combined with prolonged 
exposure might lead to an increased dose of UVA. Therefore, there is an urgent 
need to develop better protective UVA blockers. However, independently of the 
UVA/UVB blocking quality of the available sunscreens, the focus of UV protection 
should be aimed at increasing public awareness about the harmful effects of both 
UVB and UVA radiation. To be effective, these campaigns need to be based on 
scientiﬁc evidence that explains the detrimental health effects of UV exposure, 
such as the evidence provided in this thesis, and to encourage people to avoid 
unhealthy habits and behavior in getting a tan. 
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